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3To my family
4A day without laughter is a day wasted - Charlie Chaplin
5AbstrAct
Most AAAs contain an intraluminal thrombus (ILT) and the volume of the ILT correlates 
with aneurysm size. The thrombus-covered wall is a common site for rupture after bleeding 
into the ILT. 
The hypothesis for this thesis was generated when Kazi et al discovered differences in AAA 
wall between ILT covered and ILT free aortic wall. From computed tomography images of 
patients with abdominal aortic aneurysms containing an eccentric intraluminal thrombus, 
the aortic wall appeared to be partially in direct contact with the blood flow on one side, 
while the opposite aortic wall was covered by the ILT. In that study they concluded that the 
aorta portion situated under the ILT is thinner, with fragmented elastin fibers, apoptosis of 
smooth muscle cells and generally is more degraded compared to the AAA wall, which is 
not under the ILT. This characteristic difference was postulated to be due to mere presence 
of the ILT. In this thesis we investigated the role of the ILT in AAA by concentrating on the 
content of the ILT in terms of proteases and their activities and inhibitors.
We have collected ILT and AAA wall from 57 patients (14 women, 43 men) obtained dur-
ing elective surgery and examined them by proteomic methods.
We have found that MMP1-2-9, and13 and elastase and inhibitors, a-1 anti-trypsin, TIMP-
1 and PAI-1 are present in the various layers of the ILT, but mostly active in the layer adja-
cent to blood flow. We also found significant amounts of MMP9 in complex with N-GAL in 
AAA tissue. Activity of MMP9 is preserved upon binding to N-GAL. Further, unpublished 
data show that membrane bound proteases are present and carried by microvesicles and are 
active in the ILT, particularly in the acellular layer of the ILT adjacent to the aortic wall. 
In summary, ILT contains various active proteases. These proteases may contribute to deg-
radation of the vessel wall and concomitantly lead to AAA rupture.
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AbbreviAtions
AAA abdominal aortic aneurysm 
Abl abluminal 
ADAM A Disintegrin And Metalloprotease
CaCl
2 
calcium chloride
COPD Chronic obstructive pulmonary disease 
CT computed tomography 
EDP elastase-derived peptides 
ELISA Enzyme-linked immunosorbent assay 
EVAR endovascular aneurysmal repair 
FDP fibrin/fibrinogen-degraded products 
If interface fluid 
IHC immunohistochemistry 
ILT intraluminal thrombus 
JNK c-JNK N-terminal kinase 
LDL low-density lipoprotein 
Lum Luminal 
MASS Multicenter Aneurysm Screening Study 
Mid Middle 
MRI magnetic resonance imaging  
MMP1 matrix metalloproteinase 1 
MMP2 matrix metalloproteinase 2 
MMP9 matrix metalloproteinase 9 
MMP13 matrix metalloproteinase 13 
MV microvesicle 
nAChR nicotinic Acetylcholine receptor 
NE neutrophil elastase 
N-GAL neutrophil gelatinase-associated lipocalin 
NTh non thrombus wall 
NTVW Non thrombus vessel wall 
OR open repair 
PAI-1 plasminogen activator inhibitor type 1 
P4H  prolyl-4 hydroxylase 
SNP single nucleotide polymorphisms 
TAT thrombin-antithrombin III complex 
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TACE TNFα converting enzyme 
TEM Transmission electron microscopy 
Th thrombus wall 
TIMP1 tissue inhibitors of metalloproteases  1 
TIMP2 tissue inhibitors of metalloproteases 2 
TIMP3 tissue inhibitors of metalloproteases 3 
TIMP4 tissue inhibitors of metalloproteases 4 
TNFα tumor necrosis factor alpha 
tPA tissue plasminogen activator 
uPA urokinase plasminogen activator 
TSE tobacco smoke extract 
TVW thrombus vessel wall 
US ultrasonography  
XDP neutrophil elastase degraded product
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prefAce
Why do this?
A challenge: 
A few years ago a folder with evidence collected around unresolved mysterious murders of 
elderly men and a few elderly women was given to me to investigate. Going through these 
files I noticed that all these people had a few things in common, they were aged and most 
of them smoked.  Looking closer to the data collected through the years, one additional 
fact emerged. We observed that most of the victims had something called an Intra luminal 
thrombus (ILT) that seemed to be present at the crime scene. This structure had not received 
much attention but was considered a bystander and not involved in the murder conspiracy. 
Therefore I have taken upon myself to investigate this so-called “bystander” since it be-
came more and more important to be able to solve this mystery by investigating the ILT.  
It soon appeared that this was a big challenge to try to resolve the conspiracy between 
proteases and inhibitors in the ILT. I had some experience in working with murder cases 
but these were very different. This time the victims were mostly elderly men around 60-70 
years of age. I accepted the challenge and hoped to be able to manage to add another puzzle 
piece to the vast mysterious deaths by abdominal aortic aneurysm.
Now after a few years working with these cases, we have managed to identify a few players 
that had taken part in this conspiracy. But the murderers are still out there….
14
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introduction
Definition 
Merriam Webster dictionary: Greek aneurysma	(ανεύρυσμα), from aneurynein to dilate, 
from ana- + eurynein to stretch, from eurys wide —Sanskrit uru broad, wide. 
An aneurysm is an irreversible widening of a blood vessel and occurs in the aorta and 
other vessel, e.g., intracranial and popliteal arteries. The most common location is in the 
abdominal segment of the aorta (Figure 1), but aneurysms also occur in the ascending and 
descending thoracic aorta. 
Human abdominal aortic aneurysm (AAA) and the intraluminal thrombus (ILT) that are 
generated in most AAAs are the foci of this thesis.
AAA	is	a	widening	of	the	abdominal	aorta	that	can		
							eventually	rupture	and	cause	immediate	death.
Figure 1:	An	image	of	an	elderly	male	smoker	with	an	abdominal	aortic	aneurysm	>30	mm.		
Normal	aortic	diameter	is	18.6-21.3	mm.
(Allison,	Kwan	et	al.	2008)(Yanasak,	Allison	et	al.	2008)		
16
There are several definitions of AAA in clinical use. One is when the diameter of the aorta is 
more than 50% larger than the diameter of adjacent normal aorta in that patient (Johnston, 
Rutherford et al. 1991) or 1.5 times the diameter of normal aorta in the general population 
(Upchurch and Schaub 2006). Another definition is when AAA diameter exceeds 30 mm. 
In clinical practice, the diagnosis of AAA may take in consideration that normal aortic 
diameter is dependent on age, sex, and body weight. For instance, the normal aortic 
diameter in women is smaller than in men (Sonesson, Lanne et al. 1994). These individual 
variations can be taken into account by defining the threshold for intervention when AAA 
diameter that reaches 1.5 times more than its normal size (Johnston, Rutherford et al. 
1991). The most common threshold for intervention, however, is an absolute diameter of 
55 mm or more (Lederle, Johnson et al. 2002), although this cut-off may place women 
at a greater risk for rupture. In Sweden, the 30-mm threshold is used as the definition of 
AAA, and 55 mm is the threshold for intervention. 
The standard clinical methods for assessing abdominal aortic diameter are ultrasound, 
computed tomography (CT), and magnetic resonance imaging (MRI). Nevertheless, these 
methods can give somewhat different aortic diameters for the same individual. When the 
aortic diameter is close to 30 mm, even small discrepancies amongst these methods can 
mean the difference between a diagnosis of AAA, which will require ongoing surveillance 
for the rest of the patient´s life, versus healthy aorta, which requires no surveillance. 
Therefore, it has been proposed that a more accurate and preferable definition of AAA 
should incorporate parameters for each individual, particularly the diameter of adjacent 
normal segments (Wanhainen 2008). 
Abdominal	aortic	diameter	30mm	is	considered	AAA.
Prevalence, heredity and genetics, and major risk factors
Prevalence 
AAA is a common disease that causes 2% of deaths in Western countries (Nordon, 
Hinchliffe et al. 2011). Asians, American Hispanics, and blacks are less prone to develop 
AAA (Kent, Zwolak et al. 2010).
In the Multicenter Aneurysm Screening Study (MASS), 67,800 men in the UK between 
65-74 years old were screened using ultrasound examination, during a 10-year period. 
In these individuals, a 4.9% prevalence of AAA was detected (Ashton, Buxton et al. 
2002). Another screening study in Australia of 12,200 men between ages 65-83 showed a 
7.2% prevalence (Norman, Jamrozik et al. 2004). A recent study by Svensjö et al. offered 
screening to every 65-year-old man in five Swedish counties. Over 22,000 accepted. The 
study concluded that the prevalence of AAA was the lowest of all previously reported 
studies (1.7% newly diagnosed and 2.2% total when including cases already under 
surveillance).  By comparing their results with earlier studies, Svensjö et al. inferred that 
the prevalence of AAA has decreased in the past 30 years. The decrease could be due to 
the screening of 65 year-old men in contrast to previous studies where they included a 
wider range of elderly men e.g. 65-74 (Ashton, Buxton et al. 2002). They suspected this 
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was likely to be the substantial decrease in rates of smoking among this group of men 
(from 32% in 1980 down to 11% in 2007, Statistics Sweden).  They also found an up 
to 4-fold association between AAA and smoking, independent of other risk factors (see 
Smoking, below). They propose screening of smokers in the future (Svensjo, Bjorck et al. 
2011). 
Heredity and genetics
The risk of AAA is doubled if the individual has an affected first-degree relative (Larsson, 
Granath et al. 2009), and approximately 15% of individuals with AAA have a positive 
family history (Darling, Brewster et al. 1989). Twin studies show a 10-fold higher risk to 
acquire AAA for monozygotic twins compared to dizygotic twins (Wahlgren, Larsson et 
al. 2010). Therefore it is a priority to screen first-degree relatives of AAA patients.  
Because of the heritable component of AAA, roughly two decades of studies have 
attempted to associate genetic polymorphisms with this disease. Unfortunately, many 
of these studies were too small to be conclusive, and few of the associations could be 
replicated in independent cohorts (Hinterseher, Tromp et al. 2011).  Large genome-wide 
association studies have discovered two single nucleotide polymorphisms (SNP) that 
consistently associate with AAA.  The first is on chromosome 9q33, with an odds ratio 
of 1.21 (P=4.6 x 10-10).  The SNP is within the gene encoding DAB2IP, which inhibits 
cell growth and survival. The study included 1292 patients with AAA size >30 mm and 
30,530 controls who had not been screened. The same results were confirmed by a follow-
up study of 3297 AAA patients and 7451 controls, all of European origin (Gretarsdottir, 
Baas et al. 2010). The second SNP associated with AAA is on 9p21, implicating the 
ANRIL gene, which regulates expression of two inhibitors of cyclin-dependent kinases 
(Hinterseher, Tromp et al. 2011). How variants in these two genes may lead to increased 
risk of AAA is not known (Hinterseher, Tromp et al. 2011).  
Major risk factors
 By far, smoking, male gender, and age are the major risk factors for AAA.  Family history, 
discussed above, obesity, hypercholesterolemia, clinically apparent atherosclerosis in any 
vessel, and hypertension are comparatively weak risk factors, even though hypertension 
puts extra mechanical strain on the aortic wall (Brown and Powell 1999). 
Smoking
Smoking is the most important environmental risk factor for AAA and the only risk factor 
that can be modified during disease progression. Chronic obstructive pulmonary disease 
(COPD), a condition caused primarily by smoking, is a predictor of AAA and may share 
mechanisms for matrix destruction (Murphy, Danna-Lopes et al. 1998). 
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Additional information about smoking: 
There are about 2500 substances in tobacco, and tobacco smoke contains 
approximately 4000 chemicals, many of which are created during combustion. 
From 0.3% to 5% of the mass of tobacco consists of nicotine. Nicotine is an 
alkaloid, meaning a naturally occurring compound rich in basic nitrogens. 
Some alkaloids are naturally produced from amino acids.  Serotonine, 
dopamine, and histamine are alkaloids. 
Acetylcholines are natural signaling molecules that are ubiquitously found 
in all life forms. There are two main classes of acetycholine receptors, one 
of which is called nicotinic (nAChR), because nicotine binds to this class of 
receptors and acts as a strong agonist.  Particular classes of nAChRs exist 
in the brain, mediating addictive effects (Dome, Lazary et al. 2010), and on 
immune cells implicated in matrix damage in aorta and lung (Gahring and 
Rogers 2005).  
Clearance of nicotine from the body in chronic smokers is slower than in 
occasional smokers. The most effective method to deliver nicotine into the 
reward centers of the brain is by tobacco smoke. Swallowed nicotine is not 
readily absorbed by stomach owing to the low pH of the gastric milieu. 
Nicotine and non-nicotine substances in inhaled smoke enter the alveoli of 
the lung and then nearly immediately cross into the bloodstream by passive 
diffusion.  Several non-nicotine substances in tobacco smoke have been 
implicated in slowing the clearance of nicotine, thereby augmenting its effect.  
By contrast, intravenous administration of pure nicotine appears to be less 
addictive.  Likewise, nicotine replacement products are only partially effective 
against addiction to tobacco smoking. 
Each cigarette contains 10-14 mg nicotine, of which only 1-1.5 mg is inhaled 
and absorbed. The rest of the nicotine appears in side-stream smoke (not 
inhaled) or in between puffs (Dome, Lazary et al. 2010). 
More than 80% of individuals with AAA are or were smokers. Current smokers experience 
a higher growth rate of AAA diameter than do former smokers (MacSweeney, Ellis et al. 
1994; Brady, Thompson et al. 2004). Receptors that can bind nicotine are not only present 
on neurons but also on lymphocytes and macrophages (Gahring and Rogers 2005). 
Neutrophils exposed to nicotine increase their expression of elastase (Murphy, Danna-
Lopes et al. 1998). Nicotine also activates matrix metalloproteinase (MMP2) expression 
by smooth muscle cells in the vessel wall, enhancing AAA formation in animals in vivo 
(Wang, Zhang et al. 2012). Studies in vitro indicate that tobacco smoke extracts cause 
death of human and animal smooth muscle cells, arterial and pulmonary endothelial cells, 
and human monocyte/macrophages (Raveendran, Wang et al. 2005; Hsu, Wu et al. 2009; 
Li, Yu et al. 2010).  In a large cohort study, Kent et al. showed that the number of smoke-
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years and total cigarettes smoked correlate with human AAA, and benefits from cessation 
of smoking were evident from their data (Kent, Zwolak et al. 2010). 
Tobacco	smoking	is	the	strongest	environmental	risk	factor	for	AAA,		
the	only	modifiable	risk	factor,	and	likely	plays	a	direct	causal	role	in	the	disease.
Gender and age
Other major risk factors are male gender, with a hazard ratio ≥1.97 for men relative to 
women, and age, with a hazard ratio ≥1.63 per half-decade (Rodin, Daviglus et al. 2003). 
The unadjusted gender ratio between men and women is about 5:1 (Lederle, Johnson et 
al. 2000).
In a population-based study in Norway, 6386 people between 25-84 years of age were 
recruited for ultrasound screening, which determined that 8.9% of the men and 2.2% of 
the women older than 48 years of age had AAA. The fact that no one under the age of 48 
had AAA emphasizes the importance of age in this disease (Singh, Bonaa et al. 2001). 
Obesity, high cholesterol and LDL levels, but also diabetes: Other studies show that 
excess weight correlated with increased risk for AAA (Cronin, Walker et al. 2012).  In a 
recent study, Stackelberg et al. showed that body mass index has a weak relation to AAA, 
while abdominal adiposity with a threshold waist circumference of 100 cm for men and 
88 cm for women was significantly correlated with the incidence of AAA (Stackelberg, 
Bjorck et al. 2012). Golledge and colleagues showed an association between serum 
resistin, a protein produced by adipose tissue, and AAA (Golledge, Clancy et al. 2007). 
Plasma concentrations of total cholesterol have been associated with AAA, with an odds 
ratio of 1.9 per mmol/L, and low-density lipoprotein (LDL) gives a somewhat stronger 
association, with an odds ratio of 2.3 per mmol/L (Wanhainen, Bergqvist et al. 2005). 
In another study, high plasma levels of LDL cholesterol were correlated with small 
aneurysms, suggesting a role for atherosclerosis in the initiation of the disease (Hobbs, 
Claridge et al. 2003). In addition, clinically apparent atherosclerosis in any vessel has 
been independently associated with AAA (Lederle, Johnson et al. 1997).
Strikingly, diabetes has been shown to be protective against the development of AAA, 
possibly owing to increased arterial matrix synthesis, deposition of advanced glycation 
end products that inhibit matrix degradation, and use of angiotensin receptor blockers in 
these patients (Norman, Davis et al. 2007; Thompson, Cooper et al. 2010). 
The risk of acquiring AAA is higher for patients suffering from other aneurysms. Popliteal 
aneurysm has been observed in 70% of patients with AAA (Wright, Matchett et al. 2004).
Smoking,	advanced	age,	male	gender,	and	family	history		
are	the	most	important	risk	factors	for	AAA.
Diagnosis and treatment 
Enlargement of the diameter of AAA is the major prelude to rupture (Vardulaki, Prevost 
et al. 1998). Enlargement is associated with weakening of the aortic wall, and according 
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to Laplace´s Law, the tension on the aortic wall increases with increasing diameter, even 
when the patient´s blood pressure remains the same.  Weakening of the wall combined with 
increasing mechanical tension drives further enlargement and eventually a catastrophic 
rupture of the largest artery in the body (Vorp and Vande Geest 2005).
Enlargement of AAA typically progresses for years without clear symptoms. Unfortunately, 
in many cases, the first symptoms occur during rupture, which is mostly lethal (see below). 
Thus, AAA has been called a silent killer. When symptoms occur before rupture, they can 
be nonspecific, such as lower back and side pain.  The most diagnostic sign on physical 
exam is pulsation and bulging in the abdominal region of some patients. 
Once the stress on the aneurysm wall exceeds its strength, rupture occurs. Rupture of 
AAA with extravasation of blood into the peritoneal cavity often leads to immediate 
death.  However, in many cases the bleeding is confined by the limited capacity of the 
retroperitoneal space and is associated with improved odds of survival. The overall 
mortality for patients with an acute rupture is 80%, most of whom die before reaching a 
hospital.  For those patients with an acute rupture who reach a hospital, the mortality rate 
for emergency surgical repair is 50%.  By contrast, the mortality for elective repair of 
AAA is only 5% (Cota, Omer et al. 2005), despite the invasiveness of the procedures and 
the advanced age and typical comorbidities of these patients.  
Until recently, the detection of AAA before rupture occurred by chance, either because the 
physician observed a pulsation in the abdominal region of the patient or the enlarged aorta 
was detected incidentally on abdominal imaging for another reason, such as evaluation of 
gallstones. Imaging modalities include computed tomography, ultrasound, and magnetic 
resonance imaging.  
Several groups have attempted to identify biomarkers that are raised in the plasma of 
AAA patients compared to healthy controls (Urbonavicius, Urbonaviciene et al. 2008). 
D-dimer, a product of fibrinolysis, was found to be higher on average in AAA plasma 
compared to controls (Golledge, Muller et al. 2011). Other proteins that have also been 
shown to be up regulated in plasma of AAA patient are cytokines, such as IL6, IL-1b and 
INF- g, which the latter shows to be able to predict the expansion rate of AAA (Juvonen, 
Juvonen et al. 1997). Owing to limitations in sensitivity and specificity, particularly in 
predicting rupture, none of these proteins is used to diagnose or follow AAA patients 
today (Urbonavicius, Urbonaviciene et al. 2008).
Recently screening programs have been initiated, where every male of a certain age 
(usually 65 years or older) within a geographical region is offered examination by 
abdominal ultrasound. The screening permits detection of aneurysm that would otherwise 
go unnoticed before rupture.  This type of screening saves lives and is cost effective 
(Lindholt, Juul et al. 2006). Some researchers have proposed that screening efforts focus 
on elderly and smokers.  Screening of women is less common. In a contemporary study 
in Sweden, screening over 5000 women of 70 years of age, 19 were detected with AAA, 
of whom 18 were current or former smokers. This was only 0.4% of the total cohort and 
shows that prevalence of AAA in women is much lower than that in men (Svensjo, Bjorck 
et al. 2012) therefore screening of women is considered not to be cost effective (Ashton, 
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Buxton et al. 2002).  It is known however that time-to-rupture is shorter for women than 
men (Wilson, Lee et al. 2003) and AAA related mortality rate for women is higher than 
men (Hultgren, Granath et al. 2007). 
Patients with aneurysm diameter above 29 mm are offered surveillance by regularly 
scheduled ultrasounds. Rapid expansion of AAA is an important trigger for more frequent 
ultrasound examinations, because it is associated with increased risk of rupture (Limet, 
Sakalihassan et al. 1991).  Patients in this group are offered elective surgical repair.  In 
addition, ultrasound investigations are more frequent the bigger the diameter of the 
aneurysm. Regardless of the rate of expansion, when the aneurysm exceeds a threshold of 
50-55mm in diameter, patients are offered surgery. 
AAA	patients	rarely	have	symptoms	until	it	is	too	late,	and	so	screening	
programs	have	been	established	to	detect	AAA	well	before	rupture.
Medical management 
To prevent or slow the progression of AAA, the most important strategy is cessation 
of smoking, although the best evidence for this approach is epidemiologic, not from 
large-scale, prospective, randomized clinical trials (Golledge, Muller et al. 2006; Baxter, 
Terrin et al. 2008; Kent, Zwolak et al. 2010).  In addition, anti-inflammatory agents 
(macrolides, statins), management of hypertension (propranolol, angiotensin-converting 
enzyme inhibitors, angiotensin receptor blockade), matrix metalloprotease inhibitors 
(doxycycline), and anti-oxidants have also been proposed, but evidence from large-scale 
clinical trials supporting these approaches is not available yet (Golledge, Muller et al. 
2006) (Baxter, Terrin et al. 2008). As an example, tetracycline showed benefit in animals 
given elastase to induce a model of AAA (Pyo, Lee et al. 2000).  Unfortunately, clinical 
trials in human AAA have been small and contradictory. Safety and benefit from long 
exposure time to doxycycline should be evaluated in larger cohorts (Dodd and Spence 
2011). Regarding anti-inflammatory approaches, deletion of neutrophils (Eliason, 
Hannawa et al. 2005) or mast cells (Sun, Sukhova et al. 2007) showed benefit in murine 
models of AAA, and trials of anti mast cell drugs in human AAA patients have been 
proposed (Shi and Lindholt 2012). More research is needed to identify approaches to 
inhibit the progression of human AAA. 
There	are	no	conclusively	proven	medical	approaches,	
only	watchful	surveillance	and	then	surgery	to	help	AAA	patients.
Surgical treatment 
Patients with AAA diameter exceeding 55 mm are offered elective surgery, which can be 
performed by open repair (OR) or endovascular aneurysmal repair (EVAR). Open repair 
involves exposure of the diseased aortic segment and surgical placement of a synthetic 
graft.  Endovascular repair involves the introduction of a catheter via the femoral artery, 
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followed by placement of an endograft under X-ray guidance within the lumen of the 
diseased aortic segment. Several randomized clinical trials with large cohorts have 
monitored the outcomes from these two different methods and shown an initial survival 
advantage after EVAR, but similar long-term survivals after OR and EVAR (Lederle, 
Freischlag et al. 2009; De Bruin, Baas et al. 2010; Greenhalgh, Brown et al. 2010; 
Becquemin, Pillet et al. 2011). 
The choice of method may depend on the anatomy of the aneurysm, the condition of 
the patient regarding cardiac and lung functions, and the policy of the care unit where 
the patient is treated. Endovascular repair may be preferred for patients unfit for open 
surgery, but requires regular, lifelong surveillance after the operation for possible leaks 
from the graft (called endoleaks). For AAA patients who are unfit for open surgery owing 
to comorbidities, the choice between endovascular repair and conservative non-operative 
management was addressed by randomized EVAR 2 trial, but not conclusively resolved 
(Rutherford 2006).
Elective	AAA	repair	is	recommended	for	patients	with	
AAA	diameter	exceeding	50-55	mm	who	are	fit	for	surgery.
Pathophysiology
Anatomy of the normal aorta and regional features  
that predispose to aneurysm 
The walls of every artery, including the aorta, consist of 3 layers: the tunica intima, 
tunica media, and tunica adventitia (usually called the intima, media, and adventitia). The 
intima is the innermost layer, right next to the flowing blood. This layer is composed of 
a single layer of endothelial cells anchored by connective tissue to the layer immediately 
below, which is the media. The media consists of smooth muscle cells and elastin fibers, 
collagens, and other connective tissue molecules. The third and outermost layer, the 
adventitia, consists of fibroblasts, various hematopoietic cells, neurons, small capillaries, 
and connective tissue. The cells of the aortic wall are provided with nutrition and oxygen 
via small capillaries called vasa vasorum. Aortic vasa vasora, however, are present in 
the thoracic region, but not below the renal arteries. Instead, the cells in the wall of the 
abdominal section of the aorta are supplied by diffusion from luminal blood. 
Figure 2 shows a cross section of a normal abdominal aorta. 
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 Figure 2:	A	section	of	normal	aorta	stained	with	Masson’s	Trichrome	technique,	in	which	
smooth	muscle	cells	appear	red,	collagen	stains	light	blue,	and	the	cell	nucleolus	appears	dark	
blue.	10	times	magnification.	
It has been suggested that different segments of the aorta arise from different embryonic 
origins. In a study of murine embryos, vascular smooth muscle cells in various sections 
of the vasculature had different embryonic origins.  In particular, the abdominal aorta 
diverges from the thoracic aorta. Smooth muscle cells in abdominal region of the aorta 
originate from mesoangioblasts, while smooth muscle cells from the abdominal aorta 
and femoral arteries originate from somites and various stems cells respectively (Jiang, 
Rowitch et al. 2000) (Majesky 2007). Whether the different origins of vascular smooth 
muscle cells affect the characteristics of these cells and the predisposition to aortic diseases 
are not known. Nevertheless, some authors have speculated that the embryonic origins of 
the abdominal aorta may partly explain why it is far more likely to become aneurysmal 
than its neighboring sections. 
In addition, the amount of elastin is not uniform along the length of aorta. The further 
from the heart, the fewer the elastin fibers there are in the aorta (Ahmed 1968). This 
observation was first made in 1928, when Alfred Benninghoff investigated the amount 
of elastin along the length of the human aorta and discovered a decrease in the amounts 
of elastin and collagen from proximal to distal aorta. Benninghoff estimated 60-80 layers 
of elastin in the ascending aorta, but only 20 layers in the infrarenal aorta (Wolinsky and 
Glagov 1969). 
In a later study, the infrarenal aorta was reported to have 58% fewer elastin layers, 
compared to the suprarenal aorta, and the infrarenal aorta exhibited the lowest proportion 
of elastin to collagen (Halloran and Baxter 1995). These observations provide an additional 
explanation why most aortic aneurysms are seen in the infrarenal region. 
Further evidence for structural weakness in the abdominal aorta comes from a study, 
in which the researchers used ultrasound to compute wall stress in the abdominal aorta 
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and common carotid arteries of 111 healthy individuals between ages 25-70 years. 
Measurement of luminal diameter and intima-media thickness of these vessels showed 
that age was associated with increasing diameter of the all of these arteries, but was 
compensated by additional thickness of the wall of the common carotid arteries, and so 
wall stress in these vessels remained constant with age. Some wall thickening was seen 
in abdominal aortae of older men, but was insufficient to fully compensate for the stress 
from increased vessel diameter.  Thus, wall stress in the abdominal aorta increased with 
age in men and may contribute to the development of AAA in elderly men (Astrand, 
Ryden-Ahlgren et al. 2005). 
The	abdominal	aorta	has	several	features	
that	may	predispose	it	to	aneurysm	formation.
Cells in the normal and aneurysmal aorta 
The normal aortic wall contains endothelial cells, smooth muscle cells, and fibroblasts. 
Histological studies show that segments of AAA are not lined with endothelial cells (e.g., 
see Figure 3). Aneurysmal vessels contain smooth muscle cells, but in decreased amounts 
(Kazi, Thyberg et al. 2003), and mRNA expression of alpha actin is lower in AAA vessels 
compared to healthy vessels (Mayranpaa, Trosien et al. 2009). 
Importantly, AAA segments contain platelets and inflammatory cells, particularly 
macrophages, neutrophils, and mast cells. These cells are rarely found in normal aorta. 
Platelets together with inflammatory cells produce proteases that may further damage the 
vessel (Sakalihasan, Limet et al. 2005; Wohner 2008). 
Aneurysmal	aorta	contains	inflammatory	cells	but	is	poor	in	smooth	muscle	cells.	
A comparison between Figure 2 and 3 shows clearly that the aneurysmal wall is distorted, 
and the number of smooth muscle cells (red) is decreased substantially, while collagen 
(blue) is initially overproduced.  
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Figure 3:	A	section	of	aneurysmal	abdominal	aorta	stained	with	Masson’s	Trichrome	technique.	
Compared	to	the	normal	segment	in	Figure	2,	smooth	muscle	(red)	is	decreased,	and	collagen	
(light	blue)	 is	 increased.	10-times	magnification.	The	arrow	 indicates	neovascularization.	The	
red	region	on	the	outer	right	surface	is	the	remnant	of	an	intraluminal	thrombus,	the	majority	of	
which	had	been	removed	during	open	repair.	
Matrix of the aorta
There are several macromolecules comprising the extracellular matrix of the aorta. Among 
them are laminin, various types of proteoglycans, fibronectin, collagen, and elastin. The 
relevant macromolecules to this thesis are elastin and collagen types I and III. These 
molecules provide elasticity and strength to the aortic wall, enabling it to store energy 
by distending during systole, and then recoil back during diastole, thereby maintaining 
systemic blood pressure while the left ventricle is relaxing and the aortic valve is closed. 
While elastin provides physiological strength in the form of elasticity to the vessel wall, 
collagen is required for mechanical strength at higher pressure and provides rigidity to 
the vessel. It has been shown that canine models of AAA induced by treatment of the 
aorta with elastase show dilatation without rupture, whereas treatment with collagenases 
resulted in less dilatation but was followed by rupture (Dobrin, Baker et al. 1984).  
Elastin	provides	elasticity	while	collagen	provides	strength	to	the	aorta.
Elastin
Elastin, a macromolecule in the medial layer of the aorta, enables the vessel to absorb 
the pulsatile energy from the heart, to increase aortic diameter at systole and regain its 
initial shape during diastole. Elastin is produced at early stages of infancy and must last 
throughout lifetime of an individual. Production of elastin in the aorta later in life has not 
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been detected.  Elastin has a high threshold for environmental assaults i.e. temperature 
and chemicals and has a half-life of 40 years (Rucker and Tinker 1977). 
It has been suggested that the first event in the onset of AAA is loss of elastin (Thompson 
1996; Jacob 2003). Histological studies show that AAA walls contain markedly reduced 
amounts of elastin, which is a result of the activity of elastases. The presence of neutrophil 
elastase (NE) originating from polymorphonuclear cells in AAA tissue has been 
shown to cause degradation of elastin (Fontaine, Touat et al. 2004). In addition, matrix 
metalloproteinases (MMPs) and cathepsins (Liu, Sukhova et al. 2005) also have the 
ability to degrade elastin (Herron, Unemori et al. 1991; Vine and Powell 1991; Thompson 
1996). It has been suggested that all the above-mentioned proteases have a role in loss of 
elasticity of the aortic wall and the increase of AAA diameter (Pearce and Shively 2006; 
Allaire, Schneider et al. 2009). 
Elastase-derived peptides (EDPs), which are produced by degradation of elastin, show an 
increased abundance in AAA compared to normal aorta (Petersen, Wagberg et al. 2002; 
Urbonavicius, Urbonaviciene et al. 2008). Moreover, EDPs have been shown to recruit 
inflammatory cells, which in turn produce more proteases that continue the degradation 
of elastin, leading to a vicious cycle (Satta, Laurila et al. 1998; Hance, Tataria et al. 
2002). The imbalance between protease and inhibitor exacerbates the progression of 
AAA (Cohen, Mandell et al. 1988). 
Two experimental mouse models of AAA rely on artificial damage to aortic elastin.  In 
the elastase model, the infra-renal abdominal aorta of mice is briefly clamped off, porcine 
elastase is injected into the lumen, and after a brief incubation, the elastase is rinsed 
out and normal blood flow restored. This manipulation induces aneurysm formation and 
lasting within 2 weeks of the procedure (Thompson, Curci et al. 2006). In the calcium 
chloride (CaCl
2
) model, the aorta is exposed to a CaCl
2
 solution placed briefly on the 
adventitial surface. The CaCl
2
 provokes an inflammatory reaction that disrupts the elastic 
network, leading to degradation of elastin (Chiou, Chiu et al. 2001). The aorta becomes 
aneurismal, but in the mouse, it is reversible, and the aneurysm regresses to its original 
size after 6 weeks.  
AAA	starts	with	degradation	of	elastin,	and	no	new	elastin	is	produced	after	infancy.
Collagen
Another major component of the connective tissue that gives the aorta its strength and 
rigidity is collagen. There are several types of collagen, but collagen types I and III are the 
predominant types in blood vessels. Degradation of collagens is a result of the activity of 
collagenases, such as MMP1, MMP8, and MMP13, all of which have been found in AAA 
tissue (Panek, Gacko et al. 2004).  Collagenases are capable of initiating the degradation 
of intact, triple-helical collagen. Once collagen degradation has begun, a second set of 
enzymes, called gelatinases, are able to digest partially degraded, denatured collagen. 
Gelatinases include MMP2 and MMP9 (Elmore, Keister et al. 1998). Degradation of 
elastin and collagen triggers the production of collagen in the AAA wall (Carmo, Colombo 
et al. 2002; Abdul-Hussien, Soekhoe et al. 2007), and so there is an initial increase in 
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aortic collagen content (see Figure 3). As AAA progresses, however, the degradation of 
collagen overwhelms its production, leading to rupture (Lindeman, Ashcroft et al. 2010).
During the development of AAA, the structure of the vessel wall is disrupted and the 
wall weakens (Figure 3). At later stages, production of extracellular matrix is decreased 
owing to apoptosis of smooth muscle cells, while at the same time, continued degradation 
of elastin and collagen renders the AAA wall thin (Kazi, Thyberg et al. 2003). Rupture 
occurs when the components of the disrupted aortic wall fail to withstand the mechanical 
stress from pulsatile blood flow.   
Collagens	give	the	aortic	wall	its	strength.
Proteases and their inhibitors
The proteases investigated in this thesis are introduced in Table 1, below, along with 
their inhibitors and known substrates. 
Table 1: Proteases studied in this thesis, their inhibitors, and substrates (adapted from 
(Brew and Nagase 2010; Shiomi, Lemaitre et al. 2010)). 
Neutrophil elastase: its role in coagulation/fibrinolysis and its inhibition   
by α-1-antitrypsin
Neutrophil elastase (NE) is a serine protease produced by polymorphonuclear neutrophilic 
leukocytes (neutrophils) and stored in their azurophilic granules. This protein is released 
during inflammation and has the capacity to degrade extracellular matrix, especially 
elastin.  It also has anti bacterial activity.  Elastin derived peptides (EDP) in AAA attract 
neutrophils to the AAA site (Cohen, Keegan et al. 1991).
Coagulation factors, such as factor XIII, are degraded by elastase, while factors VII, VIII, 
IX, and XII are inactivated by elastase (Schmidt, Egbring et al. 1975; Nilsson, Holmberg 
et al. 1980). Normally, tissues are protected by inhibitors of this protease.  The major 
Protease    inhibitor     substrate 
 
Elastase    α-1 antitrypsin   Elastin, Fibrin 
 
MMP1    TIMP1-4    Collagens I, II, III, VII, X, entacin, aggregan, perlecan, 
        link protein, tenacin 
 
MMP2    TIMP1-4    Gelatins, collagens IV, V, VII, X, XI, Fibronectin, Laminin,  
        Elastin, aggrecan, link protein     
 
MMP9    TIMP1-4    Gelatins, collagens III, IV, V, elastin, aggregan, vitronectin
        link protein, N-telopeptide of collagen I 
 
MMP13    TIMP1-4    Collagen I, II, III, IV, IX, X, XIV,  Fibronectin, Laminin, 
        Perlecan, tenascin, osteonectin  
 
ADAM10    TIMP1-3    ProTNF-α, delta, collagen IV, gelatin Mylein basic protein,
        L1, APP, ProHB-EGF, CD44,Notch, Delta-like1, Jagged,  
        N- and  E-Cadherin, Ephrin A2, IL6R, Ephrin A5 Fas-L   
       
ADAM17    TIMP1-3    ProTNF-α, ProTGF-α, TNF-p75 receptor, TRANCE,    
                                ErbB4, proHB-EGF, proepiregulin, proamphiregulin, 
        IL6R,  L-selectin, APP, CD44 
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inhibitor for NE is α-1-antitrypsin, which is a serine protease inhibitor generated by the 
liver and released into the blood in high amounts. The other inhibitor of elastase is called 
elafin, which is produced by epithelial cells in lung and skin. Inflammatory processes 
and involvement of matrix metalloproteinases can block the activity of α-1-antitrypsin, 
despite its saturating concentrations in the blood (Sires, Murphy et al. 1994). 
Cigarette smoke (Weitz, Crowley et al. 1987) and its major component, nicotine (Murphy, 
Danna-Lopes et al. 1998), increase NE activity and at the same time impair the ability of 
α-1-antitrypsin to inhibit elastin. These two effects lead to more activity of NE (Cohen 
and James 1982). Impairment in the ability of α-1-antitrypsin to inhibit NE is mediated 
by oxidation of one amino acid in the active site of α-1-antitrypsin, which makes its 
attachment to NE less effective (Li, Alam et al. 2009). 
NE is capable of degrading fibrin in ILT (Kolev, Komorowicz et al. 1996). Fibrin, 
however, is degraded mostly by plasmin/mini-plasminogen, and the degradation products 
are different arrangements of 2 core fibrin fragments, fragment D and E.  DD, DDE and 
E, with the major product being, DD also called D-Dimer. Plasma levels of D-dimer have 
been showed to correlate with growth of AAA (Golledge, Muller et al. 2011). NE degrades 
fibrin into a peptide, called the NE degraded product (XDP), that differs from D-dimer by 
a few amino acids and can be separately assayed (Kohno, Inuzuka et al. 2000). 
NE is capable of cleaving plasminogen to “dess Kringle 
1-4
” also called mini-plasminogen. 
Mini-plasminogen activated to mini-plasmin in a faster rate than the activation of 
plasminogen to plasmin. Mini-plasminogen is resistant to inhibition compared to 
plasminogen and also more effective at degrading fibrin. Therefore, NE can degrade 
fibrin directly or indirectly by activating mini-plasminogen (Gombas, Kolev et al. 2004). 
Consequently neutrophils leucocytes associated with thrombi contribute to fibrinolysis 
(Kolev, Komorowicz et al. 1996).
Several fibrinolysis and coagulation factors, such as thrombin-antithrombin III complex 
(TAT) and fibrin/fibrinogen-degraded products (FDP) have shown to correlate with size 
of AAA (Yamazumi, Ojiro et al. 1998).  Another component of fibrinolysis investigated in 
AAA is plasminogen activator inhibitor type 1 (PAI-1), which is an inhibitor of fibrinolysis. 
PAI-1 acts by inhibiting tissue plasminogen activator (tPA) and urokinase plasminogen 
activator (uPA), which are activators of plasminogen (Louwrens, Kwaan et al. 1995). It 
has been shown that NE is capable of inactivating PAI-1, which is yet another mechanism 
to enhance fibrinolysis (Wu, Urano et al. 1995). This degradation will facilitate bleeding 
into the ILT and increases the risk of rupture that we discuss later.
Neutrophil	elastase	degrades	elastin	and	fibrin	and	is	active	in	AAA.	
Metalloproteinases and their inhibition by TIMPs
Matrix metalloproteinases (MMPs) are proteins with a zinc-binding motif in their 
catalytic domain and are responsible for degrading collagens, gelatins, and elastin in the 
aortic wall of AAA. These proteases are involved in several biological events, such as 
reproduction, development, morphogenesis, and wound healing. They also play a role in 
protection against bacterial invasion (Shiomi, Lemaitre et al. 2010). Metalloproteinases 
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are zymogens and need cleavage of their pro domain to be activated. Plasmin, a protein 
involved in fibrinolysis, is considered to be an activator of metalloproteinases (Allaire, 
Hasenstab et al. 1998). 
The major collagenases are MMP1, MMP8 and MMP13. These proteases are able to 
degrade triple helical domain of collagens at physiological pH.  The major gelatinases are 
MMP2 and MMP9 and are  capable of digesting denatured collagen.
Tissue inhibitors of metalloproteases (TIMPs) have many biological roles, such as 
modulation of cell proliferation, anti-angiogenesis, anti- and pro-apoptosis, signaling, 
and cell migration (Brew and Nagase 2010), but the most studied function of TIMPs is the 
inhibition of metalloproteases. TIMPs 1-4 inhibit MMPs (Brew and Nagase 2010; Shiomi, 
Lemaitre et al. 2010). In one study, Lipp et al showed that TIMPs 1-3 in human AAA are 
suppressed compared to control aorta (Lipp, Lohoefer et al. 2012). The elastase-induced 
model of AAA produces a more severe phenotype in mice lacking expression of TIMP1 
(Eskandari, Vijungco et al. 2005). Because TIMPs have anti-angiogenic properties (Brew 
and Nagase 2010), a lack of TIMPs in AAA tissue could promote angiogenesis. 
In a recent study, the thickness of the ILT was correlated with the concentration of TIMP1 
and active MMP9 in the aortic wall of AAA and that showed to be independent of other 
variables, such as statin use, age, and gender (Khan, Abdul Rahman et al. 2012). 
The rupture site of AAA shows an increase in the concentrations of MMPs, such as 
MMP8 and MMP9 (Choke, Thompson et al. 2006; Wilson, Anderton et al. 2006). In the 
elastase-induced model of AAA, mice deficient in MMP9 (Mmp9-/-) showed attenuation of 
AAA progression compared to wild-type Mmp+/+ controls (Thompson, Curci et al. 2006). 
MMP9 activity is preserved when the protein binds neutrophil gelatinase-associated 
lipocalin (N-GAL), because degradation of MMP9 is halted (Fernandez, Yan et al. 2005). 
Thus, N-GAL enables MMP9 to continue to degrade collagen and elastin of AAA wall.
In	AAA,	MMPs	are	up-regulated,	while	their	inhibitors,	TIMPs,	are	suppressed.
ADAMs (A Disintegrin And Metalloprotease) are a group of proteases belonging to the 
metalloproteinase family, but several members of this group have a trans-membrane 
domain. Similar to other MMPs, ADAMs also contain a zinc-binding domain in their 
active site. ADAMs are produced as zymogens and are activated in the cytoplasm before 
they are transported to the cell membrane, where they are anchored in the phospholipid 
bilayer by their trans-membrane domain (Edwards, Handsley et al. 2008).  
ADAM10 and ADAM17, which are studied in this thesis, cleave other membrane proteins, 
causing them to become activated or shed. Tumor necrosis factor alpha (TNFα) is one of 
the proteins activated by ADAMs that possess TNFα converting enzyme (TACE) activity, 
especially ADAM10 and ADAM17 (Hiraoka, Yoshida et al. 2008).
TNFa is a cytokine produced by activated macrophages and other cells. TNFa has a 
major role in the induction of inflammation and apoptosis (Locksley, Killeen et al. 2001). 
In the elastase-induced model of AAA, mice lacking receptors for TNFa showed only 
limited development of AAA (Thompson, Curci et al. 2006). TNFa, together with c-JNK 
N-terminal kinase JNK and NonO, (a 54 kDa nuclear RNA and DNA binding protein) 
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inhibit the expression of prolyl-4 hydroxylase  (P4H), an enzyme required for synthesis 
of all collagens. Inhibition of P4H decreases collagen synthesis. TNFa and JNK also 
participate in the induction of genes, such as MMPs, that are responsible for matrix 
degradation (Yoshimura, Aoki et al. 2005; Zhang, Zhang et al. 2007).
It has been shown that ADAM17 (TACE) is up-regulated in the media and adventitia 
of the aneurysmal wall and that TNFa has a role in the pathogenesis of AAA (Satoh, 
Nakamura et al. 2004). 
In addition to TNFa, the substrates for ADAMs include other vessel-wall proteins, such 
as syndecan -1 and -4, collagen type XVII, ICAM-1 and VCAM-1 (Scheller, Chalaris et 
al. 2011). Inhibitors of ADAM10 and ADAM17 include TIMPs 1-3.
ADAMs	are	a	group	of	specialized	MMPs	that	have	
	been	implicated	in	the	pathogenesis	of	AAA.
Cathepsins, Tryptase, Chymase, Granzyme B
Other proteases that may play a role in the pathogenesis of AAA include cathepsins, 
tryptase, chymase, and Granzyme B. 
Cathepsins are cysteine, aspartyl or serine proteases that are active mostly in the lysosomes 
of cells involved in protein degradation. Twelve members of this family have been 
identified. They are active at low pH and have been indicated to have a role in elastolysis 
(Sukhova and Shi 2006; Lohoefer, Reeps et al. 2012). 
In the elastase-induced model of AAA, mice deficient in cathepsin C (Shi 2007) and L 
(Sun, Sukhova et al. 2011) were resistant to developing aneurysms. 
Active cathepsin D and cathepsin L were found in the aneurysmal wall, and their 
concentrations were higher in AAA than in healthy control aorta. The activity of these 
proteases was shown to be higher in the ILT of AAA compared to an in-vitro produced 
blood clot from donors (Gacko and Glowinski 1998). Shortly after, the same group showed 
that activity of other cathepsins, namely, cathepsin A, cathepsin D, and cathepsin G, were 
higher in the ILT than in the blood clot while activity of catehpsin B, cathepsin C and 
cathepsin E was only slightly higher in the ILT of AAA patients compared to the blood 
clot (Gacko and Glowinski 1998). In addition, plasma of AAA patients was reported to 
contain elevated concentrations and activity of cathepsin D compared to control plasma 
(Gacko, Guzowski et al. 2006).
Another group showed that cathepsin originates from neutrophils and mast cells in AAA 
tissue (Mayranpaa, Trosien et al. 2009). Mast cells also release tryptase and chymase 
during degranulation and are abundant in AAA. Both tryptase and chymase are involved in 
the activation of MMPs and cause apoptosis of smooth muscle cells in AAA (Swedenborg, 
Mayranpaa et al. 2011). 
Granzyme B is a protease produced by cytotoxic T-lymphocytes involved in antitumor 
and antiviral activities of host immune defense, and their presence in AAA tissue has been 
demonstrated (Chamberlain, Ang et al. 2010). 
Cathepsins,	granzyme	B,	and	mast	cell	proteases	may	also	participate	in		
the	pathogenesis	of	AAA.
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The Intraluminal Thrombus
Most AAAs of a size that approaches a risk of rupture contain an Intraluminal thrombus 
(ILT) (Hans et al.), which is a non-homogenous multilayer clot, that adheres to part or 
all of the dilated aortic wall. The ILT retains blood components within its fibrin mesh 
(Figure 4). 
Low sheer stress, turbulent flow within the AAA sac, endothelial injury, and platelet 
activation favor formation of the ILT in AAA (Touat, Ollivier et al. 2006) (Biasetti, Gasser 
et al. 2010). 
Distorted	anatomy	and	vascular	function	of	AAA	provoke	the	formation	of	ILT.
Arterial thrombi and venous thrombi differ in composition owing to hemodynamic factors. 
Venous thrombi are formed under low flow and are composed of fibrin, a network with 
few platelets and relatively more red blood cells. Arterial thrombi develop under high 
flow and are composed of a fibrin mesh with aggregated platelets (Bouchard, Silveira et 
al. 2001).
                        
                   Figure 4: Fluorescent	image	of	fibrin-FITC	immunostaining	of	the	ILT	
Studies show that risk of rupture of AAA increase with the thickness of the ILT (Satta, 
Laara et al. 1996; Hans, Jareunpoon et al. 2005). One explanation is that ILT volume 
correlates with AAA diameter (Shindo, Matsumoto et al. 2005), and AAA diameter 
correlates with risk of rupture. A second explanation is that the ILT itself exerts biological 
effects that destabilize AAA (Choke, Cockerill et al. 2005).  
Properties of the ILT
In platelet-rich arterial thrombi the fibers of polymerized fibrin are thinner and denser 
compared to fibrin fibers in platelet-poor venous clots (Collet, Montalescot et al. 2002). The 
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tightly arranged fibers in arterial thrombi restrict binding of tissue plasminogen activator 
(tPA) for initiation of fibrinolysis.  Moreover activated platelets releasing proteins such 
as Myosin can mask plasmin cleavage sites of fibrin (Kolev, Lerant et al. 1994). These 
effects make arterial thrombi resistant to fibrinolysis. Likewise, the dense structure of 
arterial thrombi makes them highly resistant to mechanical forces. Consequently vast 
presence of platelets in arterial thrombi enables a more stable and long lasting thrombus. 
The ILT renews as it recruits platelets and fibrinogen from flowing blood (Touat, Ollivier 
et al. 2006). In this way, the layer adjacent to the aortic wall, called the abluminal layer, 
is considered to be the oldest. The most recently generated layer, the luminal layer, is 
in contact with the blood and attracts hematopoietic cells and other blood components 
(Houard, Touat et al. 2009). The layer in between these two layers is the middle layer, 
Figure 5, panel A.
In experimental animal models of aneurysms such as the elastase-induced model (Laser, 
Lu et al. 2012) and Angiotensin II- induced model (Daugherty and Cassis 2004) some 
development of ILT has been observed. 
The human ILT consists of various layers with no distinctive borderlines between them 
(Touat, Ollivier et al. 2006). Dependent on its spatial relation to the vessel wall or blood 
flow, it differs in cell density and texture.  
Figure 5 uses several techniques to show a typical ILT. As can be seen in this figure, an 
ILT is not a homogenous structure. The different layers are most evident in the gross 
sample (panel A). The photomicrographs in panels B-D, where the density of the cells in 
various layers of the ILT are seen by nucleus staining. It is evident from this image that the 
luminal layer is the most cell-rich, while the abluminal layer is nearly acellular. Platelets 
and neutrophils are abundant in the ILT, but platelets do not stain with heamatoxylin 
due to lack of nucleus. To characterize the content of the ILT with spatial specificity, we 
decided to divide the ILT into different regions. The layer closest to the aortic wall of 
AAA is macroscopically and microscopically different from the layers farther from the 
AAA wall.
Different	layers	of	the	ILT	have	different	properties.
In calculating the strength of AAA, thickness of the ILT is used as a variable to predict 
rupture along with gender, age, normalized transverse diameter, family history, and current 
smoking (Vande Geest, Wang et al. 2006). Other studies found a correlation between 
volume of the ILT and AAA progression (Speelman, Schurink et al. 2010; Parr, McCann 
et al. 2011) and some researchers suggest that the rate of growth of the ILT is a predictor 
for rupture (Stenbaek, Kalin et al. 2000).
Since the abdominal region of the aorta lacks vasa vasora, the cells in the aortic wall are 
dependent on blood flow in the aortic lumen for survival. The presence of an ILT obstructs 
access of nutrient blood to the aortic wall particularly if the ILT is thick. Presence of a 
3mm thick ILT prevents the passage of O
2 
to the vessel wall (Vorp, Wang et al. 1998), 
which leads to hypoxia and concomitant neovascularization at the site of ILT-covered 
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Figure 5: ILT seen using five methods:	Panel	A)	Cross-section	of	a	typical	intraluminal	
thrombus	obtained	during	open	repair.	The	layers	are	depicted	in	the	figure.	The	thin	red	
part	is	the	luminal	layer	and	the	opposite	site,	meaning	the	grayish	part	(that	was	situated	
adjacent	to	the	aortic	wall),	is	the	abluminal	layer,	and	the	layer	in	between	is	the	middle	
layer.	Panels	B-D)	show	Haematoxylin	staining	of	each	of	the	three	layer	of	the	same	ILT.	
The	luminal	layer	is	the	most	cellular,	and	the	abluminal	layer	is	essentially	acellular.	Panel	
E)	Contrast	enhanced	computed	tomography	of	the	same	AAA	before	surgical	repair.	The	
white	line	indicates	the	thickness	of	the	thrombus.	F,	G)	T2	weighted	turbo	spin-echo	(F)	
and	Steady	state	free	precession	gradient	echo	(G)	magnetic	resonance	images	of	the	aorta	
before	surgery	at	a	level	corresponding	to	the	computed	tomography	image	E.	By	magnetic	
resonance	imaging,	different	parts	of	 the	thrombus	show	a	greater	heterogeneity	than	on	
computed	tomography.		The	red	star	shows	the	path	of	blood	flow	in	panels	A,	E,	F	and	G	
and	the	yellow	arrow	in	panels	E-G	show	the	ILT.
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AAA wall (Holmes, Liao et al. 1995; Vorp, Lee et al. 2001; Choke, Thompson et al. 2006). 
In some biopsies of an aortic wall covered by thick ILT, which obstructs the vessel from 
direct contact to the blood, neovascularization is seen (Mayranpaa, Trosien et al. 2009) 
(Thompson, Jones et al. 1996; Choke, Cockerill et al. 2006). The presence of new vessels 
facilitates entrance of inflammatory cells into the aortic wall (Reeps, Pelisek et al. 2009). 
Moreover, it has been postulated that stem cell factor produced by endothelium from 
newly formed vessels in AAA wall attracts mast cells and platelets to this environment 
(Mayranpaa, Trosien et al. 2009). Figure 3 above shows a cross section of an aneurysm 
wall. In this Figure the arrow indicates a site of neovascularization.  
Presence	of	the	ILT	causes	hypoxia,	which	leads	to	neovascularization
Cells and proteases in the ILT
Thompson et al showed that neovascularization can enhance the recruitment of 
inflammatory cells into the aortic wall (Thompson, Jones et al. 1996) and these cells can 
express and release MMPs within the weakened AAA wall (Sakalihasan, Delvenne et al. 
1996). Moreover, MMPs are capable of enhancing the activity of other proteases (Carrell, 
Burnand et al. 2006). It has also been shown that the ILT has the ability to trap proteases, 
such as MMP2 and MMP9 (Fontaine, Jacob et al. 2002) and inflammatory cells such as 
neutrophils are readily recruited into the luminal layer of the ILT (Houard, Touat et al. 
2009). Additionally, the cell population in the ILT mostly consists of neutrophils. Platelets 
are also present in all layers of the ILT, but presence of macrophages, T cells and B cells 
have not been widely observed within the ILT. 
Several cell types besides platelets are trapped within the fibrin network of the ILT. The 
consensus is that hematopoietic cells are generally trapped in the ILT (Sagan, Mrowiecki 
et al. 2012). However, CD3-positive cells (T cells), CD45-positive cells and hematopoietic 
cells except erythrocytes and platelets are not readily observed in the ILT. In contrast, T 
and B cells are found in the aneurysm wall (Ocana, Bohorquez et al. 2003). Other cells 
present in the ILT are red blood cells, which are found primarily in the luminal layer of 
the ILT with some in the middle and essentially none in the abluminal layer.
The	predominant	cell	types	trapped	within	the	ILT	are	neutrophils	and	platelets,	chiefly	
in	the	luminal	layer.
Neutrophils are well known to express several proteases. In addition, platelets are capable 
of expressing MMP1, MMP2 and MMP9 (Leza, Salas et al. 1998; Fernandez-Patron, 
Martinez-Cuesta et al. 1999; Galt, Lindemann et al. 2002). During clot formation, platelets 
directly recruit neutrophils. Activation causes platelets to display P-selectin and b2 and 
b3 integrin on their surface, and these molecules bind counter-receptors on neutrophils. 
Platelets also induce neutrophils to produce cytokines and release granules that contain 
proteases, such as elastase and MMPs (McEver, Moore et al. 1995). Neutrophils posses 
three types of granules: primary, secondary and tertiary.  Primary granules are identified by 
the presence of myeloperoxidase, and they also contain serine proteases, such as elastase, 
cathepsin G and proteinase 3. Secondary granules contain zinc-dependent collagenases, 
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while gelatinases MMP2 and MMP9 are held in tertiary granules. These proteases are 
capable of degrading the vessel wall matrix.  Nevertheless, the presence and activity of 
these proteases within the various layers of the ILT have not been demonstrated. Red 
blood cells have been observed in the luminal layer of the ILT, but the role of these cells 
in pathogenesis of AAA have not been studied.  
ILT	traps	cells	that	produce	proteases	that	may	weaken	the	aortic	wall,	promoting	
rupture.
Effect of the ILT 
The presence of an ILT may partially compensate for the hemodynamic effects from 
arterial expansion. An ILT can restore the lumen of a distended aorta to a semi-normal 
size and to a certain extent absorbs the stress on the degraded AAA like a cushion, thereby 
lowering wall stress (Speelman, Schurink et al. 2010), in other words, ILT supports the 
redistribution of the stress on the wall (Di Martino, Mantero et al. 1998; Hinnen, Visser 
et al. 2005). This effect is important as long as the ILT is intact, but it has been shown 
that small fractures in the surface of the ILT can propagate to the wall of the aneurysm, 
concentrating the stress of the focal areas leading to rupture (Gasser, Gorgulu et al. 2008).
The	presence	of	an	ILT	may	have	both	protective	and	harmful	consequences.
The wall under the ILT (Thrombus vessel wall, TVW) and the thrombus-free wall (non-
thrombus vessel wall, NTVW) exhibit important differences. Figure 6 shows a CT image 
from an AAA patient in whom an eccentric ILT covers part of the aneurysm wall, while 
NTVW remains in contact with the blood flow. In our previous studies we showed that the 
wall under the ILT is thinner and prone to rupture compared to NTVW (Kazi, Thyberg et 
al. 2003). One study of ruptured aneurysm indicates that 80% of ruptures occur under the 
ILT (Simao da Silva, Rodrigues et al. 2000).
The difference between TVW versus NTVW was further investigated by evaluating 
computed tomography (CT) images from ruptured AAAs just before emergency surgical 
repair. In many cases, a crescent sign appears in the ILT, indicating bleeding into the ILT 
associated with rupture (Arita, Matsunaga et al. 1997). Roy et al showed that 52% of the 
ruptures occur at the site where the AAA is covered by the ILT, and 14% occur at the 
edges of the ILT, while only 34% occur at the site that according to CT images appear to 
be free from ILT (Roy, Labruto et al. 2008).
Most	ruptures	occur	in	the	weakened	aortic	wall	under	the	ILT.
Prior studies of AAA have largely focused on the dilated, damaged aortic wall.  Here, we 
focused on the ILT, in order to understand its possible role in the pathogenesis and rupture 
of AAA.  We hypothesized that the ILT contains cells that release proteases that damage 
the immediately underlying section of the aortic wall predisposing to rupture. Moreover, 
the abluminal layer, which contacts the underlying aortic wall, is nearly acellular.  Thus, 
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the major goals of this work using human material was to determine if the ILT contains 
proteases, which are enzymatically active, and if enzymatically active proteases are 
present specifically within the abluminal layer, next to the dilated aortic wall.  
 
Figure 6: A	Computed	Tomography	 (CT)	 image	 from	an	AAA	patient.	 The	 image	 shows	
sagittal	section,	 in	which	the	patient’s	anterior	abdomen	is	on	the	left,	and	the	vertebrate	
and	the	vertebral	spine	on	the	right.	The	white	winding	structure	in	the	image	is	the	blood	
flow	and	the	yellow	arrow	indicates	the	arterial	wall	under	the	grey	mass	of	the	intraluminal	
thrombus	(thrombus	vessel	wall	TVW)	while	the	white	arrow	indicates	a	nearby	section	of	
aortic	wall	that	is	in	direct	contact	with	blood	flow	(non-thrombus	vessel	wall	NTVW).	
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AiM of this thesis 
Investigating the components of the intraluminal thrombus (ILT) that could influ-
ence abdominal aortic aneurysm (AAA) pathogenesis.
Paper 1: To analyze the presence of N-GAL in AAA tissue which could enhance or pre-
serve MMP9 activity
Paper 2:  To find evidence that ILT contains active collagenases and gelatinases 
Paper 3: To investigate whether the abluminal layer of ILT that is lacking cells can harbor 
microvesicles carrying membrane bound proteases.
Supplementary Paper: To investigate mechanisms and possible importance for fibrinolysis 
of ILT by Neutrophil elastase. 
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MAteriALs And Methods
Patients
From 2006-2012, we recruited patients from the department of Vascular Surgery at the 
Karolinska Hospital. Inclusion criteria for our study were elective open repair of abdominal 
aortic aneurysm (AAA) ≥55mm in diameter, and willingness to participate in our study. 
Exclusion criteria were endovascular repair, dissection, and inflammatory aneurysm. 
Currently, there is clinical equipoise between open versus endovascular repair, but open 
surgery involves removal of intraluminal thrombus (ILT) as part of the procedure. The 
study and informed consent were approved by the Regional Ethics Committee.  
Before July 2010, patients with AAA were typically identified by chance after CT, MRI, 
or ultrasound examinations of the abdomen for other reasons.  In July 2010, ultrasound 
screening for AAA was introduced in Stockholm County for all men 65 years of age, 
and patients with AAA exceeding 55 mm in diameter were offered elective surgery.  We 
collected plasma samples and biopsies of aorta and intraluminal thrombus (ILT) from 
a total of 57 patients (14 women and 43 men, average age 71, all present or previous 
smokers except for one man during the five years of the study.
In open surgical repair of AAA, the abdomen is opened and the aorta is clamped from 
above, distal to the renal arteries, and distally to the aneurysmal widening, whether this 
reaches the distal aorta or the iliac arteries (Figure 1).
Figure 1:	Clamping	of	the	abdominal	aorta	in	a	case	where	widening	of	the	iliac	arteries	is	not	
present.	
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The enlarged aorta is opened longitudinally and the aneurysmal section of the aorta is 
removed and replaced by a synthetic graft. In most cases, an ILT is present, and removed 
as well (Figure 2). Sometimes, a fluid in the region between ILT and the underlying 
wall can be obtained; when possible, we collected that liquid as well, which we termed 
“interface fluid”.
Figure 2:	A-The	bulging	aorta	is	seen	here,	viewed	from	the	outside,	after	opening	the	abdomen	
but	before	clamping	and	opening	the	aneurysm.		Panels	B	and	C	show	images	of	an	ILT.		The	
arrow	(B)	and	asterisk	(C)	mark	the	passage	for	the	flow	of	blood	(B,	C).	
Samples collected
Blood samples anti-coagulated with either EDTA or citrate was obtained before surgery. 
Since platelets can carry proteases of interest in our study, we decided to prepare platelet 
free plasma by two centrifugations. Blood was centrifuged at 2500 g for 20 minutes at 
room temperature in order to remove red and white blood cells, and then the supernatant 
was centrifuged at 20,000 g for 30 minutes at 4°C to pellet platelets.  Platelet-free 
supernatants were harvested, aliquoted, and stored at -80°C until use.  Interface fluid, 
when available, was also aliquoted and stored at -80°C until use. 
The aortic biopsies that we collected were from 2 different regions of the aneurysm – 
namely, a portion of the enlarged aorta lying directly under the ILT (called thrombus 
vessel wall, TVW) and a portion of aorta which was dilated but not in direct contact with 
the intra luminal thrombus, as identified by pre-operative CT-image (called non-thrombus 
vessel wall, NTVW). For clarity see the CT-image in Figure 3. The vessel biopsies were 
prepared for RNA and protein extraction and also for immunohistochemistry (IHC), as 
described below.
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Figure 3:	Computed	tomography	(CT)	image	from	a	large	abdominal	aortic	aneurysm.	
This	image	is	a	cross	section	of	abdomen	of	the	patient.	In	this	image,	the	ILT	can	be	seen	
covering	one	side	of	the	aneurysm	while	allowing	the	other	part	of	the	aneurysm	wall	to	be	in	
contact	with	the	blood	flow.	
For the ILT, we received the entire thrombus from surgery. At the laboratory, we divided 
each ILT into three macroscopically evident layers. The layer closest to the blood stream, 
the luminal layer, is red and to some extent elastic. The layer closest to the vessel wall, 
the abluminal layer, is a layer with the most degraded texture, appears grey and easily 
falls apart. The intermediate layer in the middle of these two was called the middle layer
Figure 4:	A	typical	Intra	Luminal	Thrombus	(ILT)	where	the	luminal,	middle	and	abluminal	
regions	of	the	ILT	are	macroscopically	evident.	Scale	unit	is	centimeters.
Most ILTs collected had these distinct characteristics. The ILTs that differed had non-
distinguishable layers. These ILTs were not included in the study. The samples of ILT 
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that we collected were divided for various purposes. Parts of the samples were frozen for 
protein studies and part was fixed with zinc formaldehyde and dehydrated and embedded 
in paraffin for IHC. The 3 layers of the ILT were separately processed for protein extraction 
and IHC.
Protein extraction 
ILT and vessel biopsies obtained at surgery were snap frozen in dry ice. Frozen pieces (0.1-
0.6 g) were thawed later and cut into small pieces, placed in 2 ml tubes containing small 
(1.4mm in diameter) porcelain spheres and 1.0 ml RIPA buffer at pH 8.  Homogenization 
was performed with a PhastPrep machine (FastPrep FP120 Homogenizer, BIO101/FP120, 
Lab Recyclers, Gaithersburg, MD) with mechanical agitations of 20 seconds separated by 
2-min cooling periods resulting in a homogenous suspension.  Protein quantification kit 
(Thermo scientific, Rockford, IL, USA) was used to determine the total concentration of 
all protein extracts.
We also tried to extract protein using the older method of Urea-extraction. This method is 
robust but tedious. A concentration determination of the total protein amount from both 
methods showed that the difference is negligible. Thus we continued with the method 
described earlier.  
Enzyme-linked immunosorbent assay (ELISA)
This method enables quantification of the concentrations of specific proteins. Because of 
our interest in collagenases and gelatinases, we purchased ELISA kits to measure MMP1, 
MMP2, MMP9, MMP13, Neutrophil Elastase (Paper II), N-GAL/MMP9 (Paper I), and 
assayed ILT protein extraction and plasma of the patients. Peptides from degradation 
of fibrin by elastase (XDP) were measured with a specific monoclonal antibody anti-
elastase-XDP clone IF-123 from Cosmo Bio Co. Ltd., (Tokyo, Japan) in sandwich ELISA 
assay developed in our laboratory (ongoing project). 
Proteases that were present in the AAA tissue with high concentrations were further 
analyzed.  MMP9, Neutrophil elastase (Paper II) and ADAM17 (Paper III) were also 
analyzed for their enzymatic activities.  
Real time reverse-transcriptase quantitative PCR (qPCR)
This method enables us to quantify levels of specific mRNA expressed in tissues. For this 
analysis, we obtained vessel wall biopsies from AAA patients, both TVW and NTVW. 
Aortic tissue samples were fixed in RNA-Later (Qiagen, Sweden) at 4° C for 24 hours and 
stored at -80ºC before RNA extraction using the RNA-extraction kit from Qiagen. We 
also tried to extract RNA from all layers of the ILT but the amount of RNA and its quality 
was not sufficient for further analysis, consistent with the relatively low numbers of cells, 
particularly in the abluminal layer. In paper III the aortic tissue was divided to media and 
adventitia for better understanding the cell types that express ADAM10 and ADAM17.
Quality and quantity of RNA were analyzed by an Agilent 2100 Bio analyzer (Agilent 
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Technologies, Paolo Alto, CA, USA). cDNA was produced from mRNA and real time 
PCR assay was performed. Primers for N-GAL (Paper 1), ADAM10	and ADAM17 (paper 3) 
Ribosomal protein large P0 (RPLP0) was used as a housekeeping gene for normalization. 
Samples were run on a (Bio-Rad, DNA endine, Tetrad2, Peltier thermal cycler), and data 
analysis was performed using the manufacturer’s software Applied Biosystem , “7000 
system software” version 1.2.3. and Excel-based software packages for determining the 
values and Statistica software for the statistic.
Co-immunoprecipitations, and zymography
In Paper I, we were interested to find out whether N-GAL in AAA tissue is physically 
associated with MMf9. Therefore, protein extracted from ILT and the aortic wall of AAA 
was immunoprecipitated with an antibody against N-GAL, followed by immunoblotting 
for MMP9. Agarose beads are used to bind antibody against the protein of interest. Adding 
the antibody-bead to the protein suspension allows the protein of interest to pellet after 
a centrifugation step. Pellet will include protein of interest and its physically associated 
proteins. An immunoblot in reducing condition will facilitate the disassociating of bonds 
to investigate single proteins further.
Investigating the activity of gelatinases such as MMP2 and MMP9 is possible by 
Zymography. To perform this method, an electrophoresis zymogram gelatin gel was used. 
These gels and buffers needed were purchased from Bio-Rad (Stockholm, Sweden).
Once the samples were loaded to the vertical zymogram, we electrophoresed at 100 volts 
for 3-4 hours. After electrophoresis, gels were incubated with a renaturing buffer that 
allows the MMPs to undertake their original structure and become activated. The gel was 
then incubated in developing buffer overnight at 37 °C to allow digestion of the gelatin 
in the gel to occur. Then the gel was stained with coomassie blue for 10 min followed 
by several washes. Clear bands in a dark blue background emerges after 3rd -4th washes. 
These bright bands are a result of activity of MMPs in the sample. An electrophoresis 
marker is used as a reference to estimate the weight of the proteases that degraded the gel 
on different lanes. These bands will appear at the estimated weight for pro- MMPs and 
active MMPs where the difference is a few kDa. (Pro-MMP9 92 kDa and active MMP9 
83 kDa, Pro-MMP2 is 72 kDa and its active form is 62 kDa).
Immunohistochemistry (IHC)
The presence and distribution of specific cell types and proteins in tissue sections can be 
observed with IHC. In this method, antibodies against a cell marker or protein of interest 
are used to stain the sections. The ILT and vessel biopsies from surgery of AAA patients 
were fixed in Zinc formaldehyde (Histolab, Göteborg, Sweden), with a 20:1 volume ratio 
to the tissue for a proper fixation. After 24 hours of fixation the tissue was kept in 70% 
ethanol until further dehydration. Tissues were then dehydrated using a VIP dehydration 
machine (VIP 2000B, SAKURA, USA).  The specimens were then embedded in paraffin 
and sectioned at 5µm thickness. The sections were rehydrated followed by an antigen 
retrieval step, using DIVA buffer and background blocking using Sniper. After this step 
the sections were incubated with primary antibodies, one hour in room temperature 
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followed by secondary antibodies, then stained using the chromogens DAB or Vulcan 
fast red which are stable chromogens or Frangi blue that is less stable. All the reagents 
belong to MACH II and III systems (Biocare Medical, Concord, CA, USA). 
We focused on cells and proteins in the ILT and vessel wall of AAA. In Paper I, we used 
antibodies specific for, neutrophils (anti-CD66acd), MMP9, and N-GAL. In Paper II we 
stained ILT sections with markers for macrophages, (CD163), neutrophils (CD66acd), 
mast cells (anti tryptase), and platelets (anti-CD61), although in this paper, figure 2 states 
CD161, which is incorrect. In Paper III, we examined the membrane bound proteases 
ADAM10 and ADAM17 in the ILT and AAA tissue.
Transmission electron microscopy (TEM)
This method allows monitoring small components of tissue down to sizes around 
100nm in diameter. The method was used in Paper III, where the presence of membrane 
microvesicles (MVs) was verified. To perform immunostaining by TEM, the secondary 
antibody is attached to a small gold particle, which appears as a solid, electrodense circle 
in the images. In the case of double staining, the sizes of those particles (5 and 10 nm) 
differ and allow the distinction between different antibodies.
Fresh ILT and AAA vessel wall were collected from surgery and fixed in 3% 
paraformaldehyde in 0.1 M phosphate buffer and infiltrated into 2.3 M of sucrose. 
The further preparation of samples for EM microscopy was carried out at the Electron 
Microscopy Core Facility of Karolinska Institutet. See the procedure from this facility 
below.
Immunoelectron microscopy (iEM)
Samples were fixed in 3 % paraformaldehyde in 0.1 M phosphate buffer and infiltrated 
into 2.3 M sucrose and frozen in liquid nitrogen. Sectioning was performed at -95°C 
and placed on carbon-reinforced formvar-coated, one hole Nickel grids. Immunolabelling 
procedure was performed as follows: grids were placed directly on drops of 0.15 M sodium 
cacodylate (caco) buffer containing 2% BSA (Sigma fraction V) and 2% Fish gelatin 
(GE Healthcare, Buckinghampshire, UK). Sections were then incubated with the primary 
antibodies ADAM 10 (goat) + CD61acd (mouse) and ADAM 17 (mouse) + CD 66 (rat) 
in 0.15M of caco containing 0.1% BSA + 0.1% Gelatin (CBG) over night in a humidified 
chamber in refrigerator. The sections were thoroughly washed in the same buffer and 
bound antibodies were detected with Goatαmouse (5nm gold) + Rabbitαgoat (10nm gold) 
respectively Goatαmouse (5nm gold) + Goatαrat (10 nm gold) (Biocell, BBInternational, 
Cardiff, England) at a final dilution of 1:100. Sections were rinsed in 0,15M buffer and 
fixed in 2% glutaraldehyde and contrasted with 0,05% uranyl acetate and embedded in 
1% methylcellulose and examined in a Tecnai G2 Bio TWIN (FEI company, Eindhoven, 
The Netherlands) at 100 kV. Digital images were taken by a Veleta camera (Soft Imaging 
System GmbH, Műnster, Germany) (Qinyang et al, 2004)
Qinyang, W., Hultenby, K., Elhassan, A., Lindgren, U. Galanin in adjuvant arthritis in the 
rat J Rheumatology 31:2, 302-307, 2004
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Flow cytometry
In Paper III, we used this method to analyze fresh tissue extracts from the ILT, for 
membrane-bound proteases carried on small particles such as MVs. Human AAA tissue, 
ILT and vessel wall samples were collected from surgery. Freshly collected biopsies were 
first rinsed 3 times in PBS, that we had filtered to remove any particulate matter that 
would produce artificial signals on flow cytometry. The rinsed tissue samples were then 
minced into small pieces in filtered, phenol-red-free MEM medium with 0.2% BSA (200 
mg tissue per ml of MEM) and fixed 1h in 1% paraformaldehyde (PFA), followed by 
low-speed centrifugation at 1000 X g for 15 minutes at 4°C to remove the tissue chunks 
and debris. Supernatants were then centrifuged at 12600 X g for 5 minutes to remove any 
potential debris residues. Finally, these supernatants were divided into aliquots that were 
stored in freezer (-80°C) tubes (screw-tops with air-tight O-rings) for later analysis by 
flow cytometry. 
We have tested these samples for presence of ADAM10 and ADAM17 and Neutrophil 
cell marker (CD66). For each antibody we used isotype control, as negative control. We 
also showed presence of MVs by using AnexinV. This protein binds to Phosphatidylserine 
on membrane of MVs. However, activated platelets also express Phosphatidylserine but 
we gated for size (200nm-1µm in diameter) and by that eliminated platelets (2–3 µm in 
diameter). Latex beads were used as a reference for MV counts.
Immunoblots
This method shows presence and molecular weight of the protein of interest in tissue 
extracts. We used this method in Paper I to demonstrate the presence of MMP9 in a 
complex with N-GAL. In Paper II, immunoblotting was used to show the presence of 
MMP9 in complex with TIMP1, which inhibits MMP9 in a 1:1 molar ratio. In Paper 
III, immunoblotting showed the presence of ADAM10 and ADAM17 in lysates from 
neutrophil cell lines treated with tobacco smoke extract.
Cell-culture studies
Smoking is the leading environmental risk factor for AAA. Almost all AAA patients 
are or have been smokers, including the ones in this study. In Paper III, we studied the 
effect of tobacco smoke extract (TSE) on cultured cells by measuring their production 
of proteolytically active MVs in vitro. Because we identified neutrophil MVs in human 
ILT, we studied the human neutrophil cell line HL-60. Tobacco smoke extract (TSE, 
100%) was prepared by extracting mainstream smoke from four cigarettes through 
culture medium For dose response studies, cells were assessed after 24 hours of exposure 
and then harvested simultaneously. At the end of these treatments, cells were assessed 
for ADAM10 and ADAM17 expression by immunoblotting. Microvesicles were pelleted 
from medium by ultracentrifugation at 100,000 g and their content of ADAM proteases 
was also assayed by immunoblot. 
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Statistics 
Data were analyzed using Statistica and Prism software. We used non-parametric 
Wilcoxon and Spearman tests, because the data sets were not normally distributed.  
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resuLts And discussions
The overall aim of this thesis was to investigate the role and significance of the ILT in the 
pathogenesis of human AAA. The majority of AAAs with a diameter indicating risk of 
rupture contain an ILT, and the vessel wall under the ILT is disrupted and thinner compared 
to the AAA vessel wall that is not situated under an ILT. Therefore, investigating specific 
molecular constituents of the ILT that could participate in the degradation of the AAA 
wall became our overall focus. We assessed the presence and enzymatic activities of a 
series of soluble and transmembrane proteases in different layers of the ILT and within 
the AAA wall. 
Paper I 
(investigating the presence of MMP9 complexes with N-GAL in  
the ILT and AAA wall) 
Why study MMP9?
Matrix metalloproteinase 9 (MMP9) is a gelatinase (Sakalihasan, Delvenne et al. 1996; 
Wilson, Anderton et al. 2008) that has been suggested to be a major matrix degrading 
enzyme in AAA. Active MMP9 is capable of degrading components of extracellular 
matrix, such as elastin and moderately damaged or denatured collagen. Lack of intact 
elastin and degradation of collagen are hallmarks of AAA. In this paper, we concentrated 
on MMP9 and its association to neutrophil gelatinase associated lipocalin (N-GAL), a 
small protein that complexes with MMP9 to sustain the gelatinase activity of MMP9 
(Fernandez, Yan et al. 2005). Expression of MMP9 and N-GAL has been shown to depend 
on c-JNK N-terminal kinase (JNK), a mitogen-activated protein kinase. Furthermore, an 
inhibitor of JNK, (SP600125), reduced the amount of the N-GAL/MMP9 complex in ex-
vivo and cell-culture experiments (Yoshimura, Aoki et al. 2005). We hypothesized that 
N-GAL might be present in AAA wall and thereby increase the activity of MMP9. 
Presence of N-GAL in AAA tissue
As an initial step, we assessed the presence of N-GAL in AAA tissue samples. 
Immunostainings of AAA vessel wall provided our first evidence for the presence of 
N-GAL. In the thrombus vessel wall, N-GAL was detected mainly in the interface between 
the thrombus and the underlying wall, although some staining could be detected within 
the wall itself. Furthermore, N-GAL staining was diffuse, not associated with cells in 
the thrombus, indicating that it had been secreted or otherwise released. Cells-associated 
N-GAL was seen in the medial layer of the non-thrombus vessel wall (see Origin of 
N-GAL, below). We then performed quantitative real-time reverse transcriptase PCR 
(qPCR) mRNA in the thrombus and non-thrombus AAA wall. Levels of N-GAL mRNA 
were low and did not show any significant difference between these wall segments (mean 
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Ct of 38 ± 2, mean ±SD). These results indicated that N-GAL protein is present in the 
AAA wall, but mRNA levels were low, consistent with little ongoing local synthesis.
Origin of N-GAL
As the name N-GAL implies, neutrophils were originally identified as the main source 
of N-GAL. Nevertheless, it has recently been shown that both monocyte-derived 
macrophages and smooth muscle cells have the ability to produce N-GAL (Bu, Hemdahl 
et al. 2006; Hemdahl, Gabrielsen et al. 2006). In our study, staining of consecutive tissue 
sections, as well as double stainings, showed that N-GAL expression in the AAA wall co-
localizes with areas containing cells expressing CD66b, a neutrophil marker.  This finding 
could explain the low N-GAL mRNA levels found in the vessel wall, since neutrophils 
have a much shorter life span than their secreted proteins. 
Association of N-GAL with MMP9
The central objective of this study was a potential association between N-GAL and MMP9 
in AAA tissues. Here, we continued with immunoblotting under non-reducing conditions. 
The non-reducing condition allows protein complexes to remain intact. To visualize the 
composition of the complex, the membranes were incubated with antibodies against both 
MMP9 and N-GAL in a consecutive order with a stripping step in between. 
This analysis revealed that N-GAL/MMP9 complexes were present in both vessel walls 
under ILT and free from the ILT and also within the ILT. Larger complexes than the 
expected 1:1 associations were also identified (135 kDa and >250 kDa). Whether these 
complexes contained additional proteins is not known.
At a later stage, we attempted to investigate this composition by mass spectrometry to 
determine the constituents of these complexes. The band, however, included various 
proteins that overshadowed the protein complex of interest, so that a clear distinction was 
not possible. 
We further investigated the association between N-GAL and MMP9 using several 
additional methods. We used immunohistochemistry to double stain AAA tissue with 
antibodies against N-GAL and MMP9. Their association was seen in the images as co-
stained spots (Figure 1).
Next, we used co-immuno-precipitation to resolve the composition of the complex. We 
used an antibody against N-GAL to capture the N-GAL protein in protein extracts of 
AAA tissue. After centrifugation to obtain the immuno-precipitated pellet, we performed 
immunoblots under reducing conditions to detect MMP9 protein. Importantly, we found 
that the MMP9 protein that co-immuno-precipitated with N-GAL was in its active, mature 
form, i.e., with a molecular weight of 83 kDa, indicating that the pro-peptide had been 
cleaved off. Mature MMP9 in a complex with N-GAL was observed within the aneurysm 
wall, the interface fluid, and all three layers of the ILT (Figure 2). 
 
49
iÃÃ] >â iÌ >°   iÝ«ÀiÃÃ  
{Î£
V«Ì>Ì >>ÞÃiÃ]  É* V«iÝiÃ ÜiÀi `iÌiVÌi` 
> >>ÞÃi` Ài}Ã°  >À}iÀ ÓÓä > V«iÝ Ü>Ã >Ã >LÕ
`>Ì  > Ài}Ã° /Ã V«iÝ >Þ VÌ> ÌÜ * 
iVÕiÃ >` i   iVÕi ­Î®° ÕÀÌiÀÀi] Ã>
>ÕÌÃ v > £Îx > V«iÝiÃ] «ÀL>LÞ ÀiviVÌ} > *
iÀÉ  iÀ V«iÝ] VÕ` Li `iÌiVÌi`  Ìi
ÌÀLÕÃvÀii Ü>] Ìi ÌiÀv>Vi vÕ` >`  Ìi Õ> Ài}
v Ìi ÌÀLÕÃ°  >``Ì] > Ã> >ÕÌ v >  Óxä > V
«iÝ VÌ>} LÌ* >`   «ÀÌi Ü>Ã `iÌiVÌi` 
> Ài}Ã° /i iÝ>VÌ V«ÃÌ v ÌÃ V«iÝ Ã ÕÜ°
i>Ì }i âÞ}À>«Þ `iÃÌÀ>Ìi` Ì>Ì > £Îx > V«iÝ
>` >  Óxä > V«iÝ VÌ>i` }i>Ì>Ãi >VÌÛÌÞ ­}° È
®°
+Õ>ÌvV>Ì v Ìi  É* V«iÝ ÕÃ} >
- VvÀi` Ìi «ÀiÃiVi v Ìi V«iÝ ÜÌ > >>
Þâi` ÃiVÌÃ v Ìi ÌÀLÕÃ >` Ìi ÛiÃÃi Ü> ­}° Ç®° /i
}iÃÌ VViÌÀ>Ì v Ìi V«iÝ Ü>Ã vÕ`  Ìi Õ>
«>ÀÌ v Ìi ÌÀLÕÃ° /iÀi Ü>Ã  Ã}vV>Ì `vviÀiVi  Ìi
>ÕÌ v V«iÝ LiÌÜii Ìi ÌÜÜ> Ài}Ã ­«>Ài` ÌÌiÃÌ®°
ÃVÕÃÃ
/i «ÀiÃiÌ ÜÀ `iÃÌÀ>ÌiÃ Ì>Ì  É* V«iÝiÃ
>Ài «ÀiÃiÌ  `vviÀiÌ Ài}Ã v Ìi° «ÀÌ>ÌÞ]  É
* V«iÝiÃ >Ài «ÀiÃiÌ  Ìi ÌÀLÕÃ ÌÃiv >`  Ìi
ÌiÀv>Vi vÕ` LiÌÜii Ìi ÌÀLÕÃ >` Ìi Õ`iÀÞ} ÛiÃÃi
Ü>°/iÃi v`}Ã ÃÕ««ÀÌ Ìi VVi«Ì Ì>Ì Ìi Ü> Õ`iÀÞ}
Ìi ÌÀLÕÃ Ã `i}À>`i` LÞ iâÞ>ÌV >VÌÛÌÞ Ài>Ìi` Ì Ìi
ÌÀLÕÃ ­£Óq£{®°
"ÕÀ ÃÌÕ`Þ ÃÕ}}iÃÌÃ Ì>Ì iÕÌÀ«Ã >Ài Ìi> ÃÕÀVi v Ìi
  `iÌiVÌi`  Ã ÃVi   iÝ«ÀiÃÃ VV>âi`
ÜÌ Ìi «ÀiÃiVi v 
ÈÈL >` 
ÈÈ>V` iÝ«ÀiÃÃ} ViÃ° Ì
V>Ì Li iÝVÕ`i` Ì>Ì >VÀ«>}iÃ V>âi`  Ìi Ã>i Ài
}Ã >Ã iÕÌÀ«Ã >Ã VÌÀLÕÌi Ì   iÝ«ÀiÃÃ° Ü
iÛiÀ] ÃVi   VÕ` Li `iÌiVÌi`  >Ài>Ã VÌ>} LÌ

ÈÈL >` 
Èn iÝ«ÀiÃÃ} ViÃ LÕÌ Ì  >Ài>Ã ÜÌ Þ

Èn iÝ«ÀiÃÃ} ViÃ] ÌÃ >À}ÕiÃ >}>ÃÌ 
Èn iÝ«ÀiÃÃ}
ViÃ Li} > >À ÃÕÀVi v  ° "ÌiÀ Vi ÌÞ«iÃ >Ûi Lii
ÃÜ Ì iÝ«ÀiÃÃ  ] ÃÕV >Ã À>Ì ÞL>ÃÌÃ ­£Ç®] LÀV>
i«Ìi> ViÃ ­£n® >` 		ÉV Î/ÎÕÃi vLÀL>ÃÌÃ ­£®° 
}ÕÀi {\   >` * >Ài iÝ«ÀiÃÃ
i`  Ìi ÌÀLÕÃ° ,i«ÀiÃiÌ>ÌÛi «VÌÕÀiÃ
v ÕÃÌViV> ÃÌ>} v VÃiVÕ
ÌÛi ÃiVÌÃ v Õ> ÌÀLÕÃ° ®  
ÃÌ>}Æ 	® 
ÈÈL ÃÌ>}Æ 
® * ÃÌ>}Æ
® }£ ÃÌ>} >Ã i}>ÌÛi VÌÀ°
}ÕÀi x\ ÕÃÌViV> `ÕLi
ÃÌ>} v * >`    Õ>
ÌÀLÕÃ°® * Ü>Ã ÃÌ>i` ÜÌ iÀ
>} LÕi ÜiÀi>Ã   Ü>Ã ÃÌ>i` ÜÌ6Õ
V> >ÃÌ ,i`] VV>Ã>Ì v Ìi ÌÜ >Ì
L`iÃ >««i>ÀÃ «ÕÀ«i ­LÕi ³ Ài`®° 	® ,iÀ
,i` ÃÌi>` v «À>ÀÞ >ÌL`iÃ vÀ *
>` ÕÃi } ÃÌi>` v Ã«iVvV >ÌL`iÃ
vÀ   ÃiÀÛi` >Ã i}>ÌÛi VÌÀ°
Figure 1:  MMP9/
N-GAL are present 
in the lumina l 
layer of the ILT.  
A)  N-GAL staining 
is shown in red and 
MMP9 is blue, no 
counterstaining  
B) Negative control  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Figure 1: MMP9/N-GAL are present in the luminal layer of ILT.
A) N-GAL	staining	is	shown	in	red	and	MMP)	is	blue,	no	counterstaining
B)	Negative	control
                    
Figure 2: Immunoblots of MMP9 in human AAA samples. 
Lane	1	shows	purified	mature	MMP9,	lane	2,	purified	N-GAL/MMP9	complex.	
Abbreviations	of	AAA	tissues	here;	interface	fluid	(IF),	ablum nal	(Abl)	luminal	(lum)	non	
thrombus	vessel	wall	(NTh).	
After showing that active MMP9 is in complex with N-GAL, we continued to measure the 
concentration of the N-GAL/MMP9 is complex in AAA tissue using a more quantitative 
method. To do so we used an ELISA kit that specifically recognizes this complex. We 
measured the concentration of N-GAL/MMP9 complex in all layers of the ILT, and AAA 
tissue under the ILT (Th) and free from ILT (NTh) as well as in the interface fluid between 
the ILT and the AAA wall. Irrespective of whether we divided the original value of the 
protein with total protein amount or wet weight of the tissue, or both, the results showed 
that the concentration of N-GAL/MMP9 complex is highest in the luminal layer of the 
ILT, and considerably lower in the rest of the ILT (Figure 3). 
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Figure 3: Concentration of N-GAL/MMP9 complex measured in AAA tissue by ELISA. A) 
Values	normalized	to	the	total	protein	in	each	sample,	B)	values	normalized	to	the	wet	weight	of	
the	tissue	before	homogenization.	(In	this	paper	the	term	Th	and	NTh	was	used	for	thrombus	and	
non	thrombus	vessel	wall.	In	later	papers	we	used	TVW	and	NTVW	denoting	these	walls).	
This distribution presumably reflects the large accumulation of neutrophils in the luminal 
region of the ILT. The luminal layer is the most recently built layer of the ILT and is 
in constant contact with the blood flow, therefore we postulate that this layer has the 
ability to trap hematopoietic cells, in particular neutrophils, that might produce N-GAL/
MMP9. Immunostaining showed that neutrophils present in AAA tissue are the major 
producers of N-GAL. Nevertheless there were also detectable amounts of N-GAL/MMP9 
complexes in the abluminal layer, although much lower than that in the luminal layer of 
the ILT and in the underlying aneurysm wall that could have implications for degradation 
of the extracellular matrix during aneurysm formation. 
MMP9 enzymatic activity
The association of N-GAL with MMP9 can preserve the enzymatic activity of MMP9. To 
analyze the activity of MMP9, we used zymography. The zymography method is based 
on incorporation of a protease substrate, in this case gelatin, into the electrophoresis 
gel. Degradation of the substrate can then be visualized as white bands in a dark blue 
background after Coomassie blue staining. The zymography showed that the ILT 
contains active MMP9. The pro form of MMP9 also appears as an active enzyme, owing 
to unmasking of the active site during the denaturation/renaturation procedure in this 
method. This method is also able to detect the presence of pro and active MMP2 (Pro-
MMP9 appears at 92 kDa and active MMP9 at 83 kDa, Pro-MMP2 is 72 kDa and its 
active form is 62 kDa).  
Take-home message
Taken together, these results show presence of enzymatically active MMP9 in complexes 
with N-GAL in aneurysmal tissue, but mostly in luminal layer of the ILT, away from the 
AAA vessel wall. These findings led us to examine other candidate proteases alongside 
MMP9 in papers II and III.
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Paper II 
(presence of soluble proteases in the ILT)
To continue our efforts to explain the degradation of the AAA wall situated under the ILT, 
we investigated the ILT in more detail in paper II. We analyzed the amounts of several 
soluble gelatinases and collagenases in the ILT, since the luminal layer of the ILT seems 
to be a dynamic tissue containing large amounts of proteins. 
Collagenases and gelatinases in the AAA tissue
Elastin and collagen, the main matrix proteins in the aorta, are degraded by neutrophil 
elastase (NE) and also MMP2 and MMP9 (Swedenborg and Eriksson 2006). We measured 
concentrations of elastase and various collagenases and gelatinases in three different 
layers of the ILT, the luminal layer facing the blood flow, the abluminal layer adjacent to 
the vessel wall and the middle layer in between the other two layers. 
Composition of a thin ILT
Dividing the ILT into three layers is only possible if the ILT is thick enough. The 
composition of a thin ILT (<10 mm) is comparable to the luminal layer of the thick ILT. 
Similar to the luminal layer of a thick ILT, a thin ILT is red and contains a large number 
of Neutrophils (Figure 4).
Figure 4: A thin ILT with many neutrophils. A) A CT image of this ILT before surgery. 
B) A photograph of the thin part (7mm) of the ILT after surgery C) the thin ILT stained with 
antibodies against CD66acd, a marker for neutrophils, and D) a negative control stain, in which 
we omitting the primary antibody.
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In a thick ILT the luminal layer contains numerous CD66acd-positive neutrophil 
leucocytes, CD61 positive platelets and to a lesser extent macrophages (CD163) and mast 
cells (identified by tryptase). 
Concentrations of NE and MMP9 and their inhibitors
We measured concentration of MMP1, MMP2, MMP9, MMP13 and neutrophil elastase 
(NE) in all three layers of the ILT. We also measured concentrations of inhibitors of some 
these proteases, TIMP1, and α-1 anti-trypsin and also PAI-1. The amounts of MMP1 and 
MMP13 were very low in all layers of the ILT. MMP2 was present with an intermediate 
amount while MMP9 and NE were present in the luminal layer, away from the AAA wall, 
with smaller amounts in the middle and abluminal layers (Table1).  
As seen in Table 1, concentrations of proteases and their inhibitors that are present in the 
different layers of the ILT varies. MMP9, NE, TIMP1 and a-1 antitrypsin were present 
in all layers of the ILT with high concentrations. Although the mere concentrations of 
the proteins are inconclusive, but when different layers of the ILT were compared, we 
observed that the amount of these proteins in the luminal layer of the ILT is significantly 
higher than in the abluminal layer. Since the luminal layer is in direct interface with the 
blood, it could be questioned if these proteins enter the ILT from circulating blood? To 
answer this question we measured the concentration of all these proteases and inhibitors in 
plasma of the same patients cohort. The results showed that the amount of these proteins 
in plasma did not correlate significantly with the proteins measured in the luminal layer 
of the ILT. 
Activity	of	NE	and	MMP9
The two proteases selected for activity measurements, MMP9 and NE, were assayed using 
specialized kits. We assayed samples from all layers of ILT and plasma of our cohort. The 
results showed that there is a measurable activity in the luminal layer of the ILT while it 
differed significantly from that in the abluminal layer, where the activity was very low 
or zero. The activity in the plasma was higher but again was not correlated with that in 
the luminal layer of the ILT, the layer in contact with the blood. The lack of activity in 
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Fig. 3. Concentration of MMP-9 ng/g wet tissue (A), TIMP-1 ng/g wet tissue (B), NE ng/g wet tissue (C) and -1 antitrypsin mg/g wet tissue (D) in luminal, middle and
abluminal ILT. Nineteen to 32 samples were used in the different groups. Wilcoxon matched pair test was used for comparison of concentration of proteases and their
inhibitors in luminal and abluminal layers of the ILT.
in the same assay. In the luminal layer only 0.7% of totalMMP-9was
active. The corresponding figures for the middle and the abluminal
layers were 0.1% and 0.04%, respectively.
An attemptwasmade to calculate themolar amounts ofMMP-9
and TIMP-1. The molecular weight for TIMP-1 is ∼24kDa and for
MMP-9 we used 87kDa, which is the average of activated and non
activated form (92 and 83, respectively). We found twofold more
molecules of TIMP-1 than MMP-9 in the lumi al layer. The molar
concentration of TIMP-1 in the abluminal layerwas 13 times higher
thanMMP-9,which suggests aneffective inhibitionofMMP-9 in the
abluminal layer. In order to further study to what extent TIMP-1 is
bound to MMP-9, we performed a native western blot to evaluate
Table 1
Concentrations and activity of enzymes and their inhibitors in luminal, middle and abluminal layers of the intra-luminal thrombus.
Luminal Middle Abluminal
Proteases
MMP-1 36 (25; 60) 36 (18; 62) 22 (20; 39)**
MMP-2 158 (99; 610) 98 (67; 249) 70 (42; 114)***
MMP-9 3459 (658; 6305) 492 (100; 1148) 278 (150; 1370)***
MMP-13 1.1 (0.3; 3.25) 0.39 (0.1; 1) 0.5 (0.3; 1.1)ns
NE 26577 (2507; 63740) 836 (274; 3496) 599 (155; 3050)****
Inhibitors
TIMP-1 1628 (650; 4100) 1851 (904; 3027) 2762 (1663; 4731)**
PAI-1 45 (16; 108) 55 (26; 96) 79 (27; 139)ns
1-Antitrypsin 1170 (298; 1880) 350(0; 720) 520 (0; 830)*
Protease activity
MMP-9 activity 5.4 (3.4; 9) 2.8 (0.6; 14) 0 (0; 0)**
NE activity 83 (5; 244) 1.96 (0.6; 38) 2.7 (0.4; 57)***
All values, median (interquartile range) are given in ng/g wet weight of the tissue. Asterisks denote levels of significance comparing results from luminal and abluminal
layers. nsNon significant.
* p≤0.05.
** p≤0.01.
*** p≤0.001.
**** p<0.0001.
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the abluminal layer of the ILT could be explained by presence of inhibitors in this region, 
where their concentrations were significantly higher compared to the luminal layer. 
NE and MMP9 are inhibited 
Further evidence for inhibiting the activity of MMP9 was obtained by immunoblot. 
Samples of AAA tissue were homogenized and protein extracts of these homogenates were 
assayed for TIMP1 in an immunoblot in non-reducing condition. The blot showed TIMP1 
both in complex with another molecule at 135 kDa and also free TIMP1 with a band below 
34 kDa. TIMP1 is a protein of 25 kDa that binds to MMP9 in a 1:1 manner and inhibits its 
activity.  When we calculated concentrations of these proteins using simple stoichiometry 
in the abluminal layer, we found several fold excess of TIMP1 compared to MMP9. Thus 
we concluded that activity of MMP9 is inhibited by TIMP1 in the abluminal layer of the 
ILT, this explained the lack of activity in our activity measurement assay, despite our 
previous finding of presence of N-GAL and the zymography assay that showed activity of 
MMP9 in a few samples. The discrepancy could be explained by the fact that in activity 
assay we sampled more biopsies than in the Zymogram. There may also be differences in 
the sensitivity of the two methods, whether the observed gelatinase activity identified by 
the zymography method is of functional relevance remains to be shown.  An additional 
explanation is that our method in paper I of co-immunoprecipitation, treatment with SDS 
and a reducing agent, electrophoresis, and then zymography would have separated MMP9 
complexes from TIMP1.
Proteolytic activity is limited to the surface of the ILT
Adolph et al. (Adolph, Vorp et al. 1997) studied the possibilities for cells from the blood 
stream to penetrate the ILT and be transferred to the vessel. They concluded that trans-
thrombotic cell migration occurs but is limited to 10 mm depth from the outer surface 
of the luminal layer of the ILT. This finding explains why the abluminal layer of the 
ILT is almost devoid of live cells. This is why we found a significant difference in the 
concentration and activity of proteases between luminal and abluminal layer of the ILTs 
that are thicker than one centimeter. In the abluminal layer we found a negative correlation 
between activity of NE and the volume of the ILT. This indicates that the thicker the ILT, 
the less activity of NE is measured in the abluminal layer of the ILT. Further evidence 
comes from a study that showed the AAA wall under a thin ILT contains more active 
MMP9 and NE compared to the wall covered by a thick ILT (Wiernicki, Stachowska et 
al. 2010). 
Take-home message
Summary of data generated in this study indicates that the luminal layer of the ILT contains 
several types of soluble proteases and cells, such as neutrophils, that are capable of 
producing proteases. The proteolytic activity of these soluble proteases, however, seems 
to be largely blocked by the presence of endogenous inhibitors. This is in agreement with 
the work of Carrel et al. where it was shown that most MMP9 in the abluminal ILT is 
latent (Carrell, Burnand et al. 2006). The findings in papers I and II led us to examine an 
entirely different class of candidate proteases in paper III.
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Paper III 
(Microvesicles as carriers of membrane-bound proteases)
Thus far, we had not found a plausible explanation for the aortic wall under the ILT 
(TVW) being more degraded than the wall “free from ILT”(NTVW). In our previous 
studies, we found very little proteolytic activity of N-GAL/MMP9, total MMP9, or 
neutrophil elastase in the abluminal layer of the ILT, adjacent to the TVW. In paper III, 
we focused on a different class of proteases, transmembrane proteases that might take part 
in the pathogenesis of AAA. 
We were particularly interested in the possibility that these transmembrane MMPs could 
reside on membrane microvesicles (MVs), which are bilayer structures that are released 
from cells upon activation or apoptosis. MVs transport biologically active molecules, and 
often survive longer and diffuse more widely than their parental cells (Giesen, Rauch et 
al. 1999; Liu and Williams 2012). Thus, we hypothesized that they might persist within 
the abluminal layer of human ILT, which is virtually devoid of cells.
Membrane bound proteases (background)
Two major members of the transmembrane class of proteases are ADAM10 (a disintegrin 
and metalloprotease-10) and ADAM17. ADAMs have overlapping substrate specificity 
as soluble metalloproteases and have been shown to function as a gelatinase (Millichip, 
Dallas et al. 1998) and are able to target several matrix proteins, such as cadherins 
and collagen type XVII (Edwards, Handsley et al. 2008). ADAM17 possesses TNFa 
converting enzyme (TACE) activity, meaning that it cleaves pro-TNFa into the active 
cytokine. TNFa has been shown to be present in the AAA aorta and expressed by 
macrophages, in contrast to control aorta (Satoh, Nakamura et al. 2004). Other substrates 
of ADAM17 include syndecan-1 and -4, ICAM-1, VCAM-1, and collagen type XVII, 
which is a vascular marix protein that may participate in pathogenesis of AAA  (Scheller, 
Chalaris et al. 2011; Zheng, Tian et al. 2012). Both ADAM10 and 17 are sheddases, 
which means that they are capable of cleaving off the ectodomain of membrane proteins 
for release. Studies in vitro show that some ADAMs are able to shed the ectodomain of 
other ADAMs, to release a soluble, enzymatically active fragment (Parkin and Harris 
2009). ADAM17 was found to be significantly up-regulated in the media and adventitia 
of the aortic wall of AAA patients compared to controls (Satoh, Nakamura et al. 2004), 
while tissue inhibitors of metalloproteinases (TIMPs) that inhibit ADAMs were shown to 
be significantly down-regulated in those regions (Lipp, Lohoefer et al. 2012).
ADAM10 and ADAM17 mRNA are present in the adventitia  
and media of AAA
In this study, aneurysmal vessels obtained at elective, open AAA repair were separated 
into media and adventitia, total RNA was extracted from these layers, and cDNA was 
produced. Real time qPCR with primers recognizing ADAM10 and ADAM17 were used 
to measure the amount of these mRNAs in the samples. The results showed that most 
of the ADAM10 and ADAM17 mRNAs were present in the media of the aortic wall of 
AAA, with some expression in AAA adventitia. 
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Figure 5: Levels	of	ADAM10	(panel	A)	and	ADAM17	(panel	B)	mRNAs	in	media	and	adventitia	
of	AAA	aortas,	as	assessed	by	real-time	qPCR.	Displayed	are	medians	(squares),	middle	two	
quartiles	(boxes),	and	ranges	(whiskers),	n=	5	NTVW	and	11	TVW.		Values	were	normalized	to	
RPLP0,	P-values	were	computed	using	the	Mann-Whitney	rank-sum	test.	
This shows that aortic tissue does have cells that express ADAM10 and ADAM17 and that 
the amount of mRNA expressed in the media is significantly higher than that in adventitia. 
The predominant cells in the media are smooth muscle cells. However there are some 
other cells types also seen in the aortic tissue of the aneurysm such as neutrophils and 
macrophages. 
ADAM10 and ADAM17 protein are present in the cell-free abluminal 
layer of the ILT, adjacent to the AAA wall
We stained human ILT and AAA samples with antibodies that recognize the extracellular 
domains of ADAM10 and ADAM17. We found that both proteases were present in these 
samples. Interestingly, both ADAM10 and ADAM17 were readily seen in the cell-free 
abluminal layer of the ILT samples. The abluminal layer is the layer directly adjacent 
to the vessel wall, and any proteases residing in this layer could potentially damage the 
underlying AAA wall.
Since ADAMs are membrane-bound proteases, and we found that they are present in 
an environment where cells are absent, we hypothesized that these transmembrane 
proteins may exist on membrane microvesicles. Microvesicles (MVs) are membrane 
blebs that bud off from activated or apoptotic cells. All cells in the body under certain 
conditions will produce MVs Radiation, chemical insults including cigarette smoke, and 
lipopolysaccharide can provoke the release of MVs by cells. By budding off from the cell 
surface, MVs can carry proteins that were embedded in the plasma membrane of the cells 
of origin. In this way, membrane-bound proteins can exist in a cell-free environment. 
Importantly, MVs can often diffuse farther and persist longer than their cells of origin 
(Liu and Williams 2012). 
P=0.002 
               Media     Adventitia 
A 
P=0.009 
               Media     Adventitia 
B 
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Microvesicles in ILT and AAA wall seen by transmission electron 
microscopy (TEM) 
We performed electron microscopy to determine if the characteristic acellular bilayer 
structure of MVs was present in ILT or the AAA wall. Biopsies from ILT and AAA aorta 
were fixed in paraformaldehyde and prepared further for TEM (see material and method). 
The luminal layer of the ILT, which faces the blood flow, contained cells embedded in a 
mesh of fibrin and red blood cells. In this layer, our TEM images did not show MVs. In 
contrast, the abluminal layer of the ILT and the AAA wall showed abundant numbers of 
acellular membrane structures < 1 µm in diameter, consistent with MVs (Figure 5). 
To determine if these membrane MV structures carried transmembrane proteases, we 
used immunogold staining, i.e., staining with gold particles of two different sizes linked 
to antibodies against ADAM10 and ADAM17. These TEM images showed MVs with 
membrane-bound ADAM10 and ADAM17. By co-staining with antibodies linked to two 
different sizes of gold particles, we found by TEM that a subset of these ADAM10- and 
ADAM17-positive microvesicles appeared to originate from neutrophils (CD66acd-
positive) and another subset from platelets (CD61-positive) (Figure 6).                  
Figure 5:The presence of 
MVs in AAA tissue. A 
shows aortic wall of AAA, 
B is abluminal layer of ILT 
and C is luminal layer of 
the ILT where MVs are 
absent. Yellow arrows in A 
and B show MVs.  
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Figure 5: The presence of MVs in AAA tissue.
A	shows	aortic	wall	of	AAA,	B	i 	abluminal	layer	of	ILT	and	C	is	luminal	layer	of	the	ILT	
where	MVs	are	absent.	Yellow	arrows	in	A	a d	B	show	MVs.
Figure 5:The presence of 
MVs in AAA tissue. A 
shows aortic wall of AAA, 
B is abluminal layer of ILT 
and C is luminal layer of 
the ILT where MVs are 
absent. Yellow arrows in A 
and B show MVs.  
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Figure 6: Doulbe goldstaining transmission electron microcopy.		Immunogoldstaining	with	
ADAM10	(black	arrow,	bigger	spots)	and	platelets	marker,	(white	arrow,	smaller	spots)	A+C.		
ADAM17	(white	arrow,	smaller	spots)	and	neutrophil	marker	(bigger	spots,	black	arrow)	B+D.	
A	and	B	in	abluminal	ILT	and	C	and	D	in	aorta.
Cellular origin of MVs with ADAMs on their membrane 
 
We investigated the cellular origin of ADAM10 and ADAM17-positive MVs by yet another 
method. We used flow cytometry of fixed extracts of the abluminal layer of human ILT 
and aorta. To detect MVs, we gated for events sized from 200nm to 1 mm that were also 
positive for annexin V. Annexin V is a molecule that binds to phosphatidylserine exposed 
on the exofacial leaflet of membrane bilayers (Montoro-Garcia, Shantsila et al. 2012). In 
normal cells, phosphatidylserine is asymmetrically concentrated in the inner leaflet of the 
plasma membrane bilayer.  This asymmetry is disrupted in MVs. Activated platelets and 
apoptotic cells, however, can also display phosphatidylserine on the exofacial leaflet that 
can bind to annexin V; hence, a major use for annexin V is the detection of apoptotic cells. 
Our size gating was chosen to distinguish MVs, which are small, from activated platelets 
and apoptotic cells (Montoro-Garcia, Shantsila et al. 2012). The two antibodies we used 
to stain the flow cytometry samples were anti-ADAM10 and anti-CD66 (a marker of 
neutrophils) in one subset, and anti-ADAM17 and anti-CD66 in another subset. The 
results from these flow cytometry experiments (Paper III, figure 4) show abundant 
neutrophil-derived MVs that also carry ADAM10 and ADAM17. There were consistently 
more neutrophil-derived MVs carrying ADAM10 than carrying ADAM17.
We have also initiated flow cytometry to detect platelet-derived MVs that carry ADAM10 
or ADAM17.
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Enzymatically active ADAM17 in AAA tissue   
Because we found ADAM10 and ADAM17 protein in the abluminal layer of the ILT 
and in aortic wall of AAA, we investigated the enzymatic activity of these proteases. 
The TACE activity of ADAM17 was easily detected in all layers of the ILT and also in 
the AAA aorta (Figure 7). Activity measurement of ADAM10 however requires assay 
development due to lack of certified commercially available assays and we are currently 
working on it. 
                                       Luminal   Middle   Abluminal  aorta 
Activity of ADAM 17  
Figure 7: Enzymatic activity of ADAM17 measured in layers of the ILT and in AAA wall
Neutrophils exposed to tobacco smoke extract (TSE) release MV 
carrying active ADAMs	
Because tobacco smoking is the leading risk factor for the development of human AAA, 
we hypothesized that transmembrane proteases and MVs in our ILT samples could have 
arisen as a consequence of smoke exposure.  To test this hypothesis in vitro, we established 
a cell-culture model by exposure of human HL-60 neutrophils to TSE. We found that TSE 
exposure induced ADAM10 and ADAM17 expression by human neutrophils in a dose- 
and time-dependent manner, shown by immunoblots of cellular extracts.  Moreover, 
TSE stimulated the cleavage of these proteases into their active forms.  Exposure to TSE 
induced apotosis of these cells, detected by TUNEL staining, in a time-dependent manner. 
Most importantly, MVs isolated from supernatants of cultured human neutrophils after 
24h of TSE exposure carry  active ADAM10, detected by immunoblots of the MV fraction 
from conditioned media (Figure 5, paper III).  
Take-home message
The studies in paper III demonstrate the presence of significant amounts of enzymatically 
active transmembrane proteases in the abluminal layer of the ILT and within the AAA 
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aortic wall. Thus, unlike the soluble proteases that we studied in papers I and II, these 
transmembrane proteases are plausible participants in the pathogenesis of AAA, because 
they are abundant, active, and located in or directly adjacent to the damaged aortic wall. 
These transmembrane ADAM proteases are present on MVs, which are membrane blebs 
that can persist long after their parental cells have disappeared. The presence of MVs in 
AAA tissue had been previously shown, but only in relation to transport of tissue factor 
and renewal of the ILT (Touat, Ollivier et al. 2006). 
Here, we showed that MVs can carry proteases and might appear as a result of cell death 
in AAA tissue. Tobacco smoke, the prime environmental risk factor for AAA, stimulated 
ADAM10 and ADAM17 expression by a human neutrophil cell line in culture, apoptosis 
of these cells, and the generation of ADAM-positive MVs that resemble the MVs that we 
found in the ILT and AAA wall. The results present a compelling pathophysiologic model, 
in which tobacco smoke stimulates immune cells to produce ADAM10 and ADAM17 and 
then export these enzymes on long-lived MVs that persist in the abluminal layer of the 
ILT and the AAA wall.  Active soluble MMPs degrade the wall, and ADAMs may take 
part in degrading matrix component of the wall of AAA and also activate TNFa (via 
TACE activity), a cytokine that recruits additional immune cells that further damage the 
aneurysm. 
Ongoing project (elastase does many things) 
Diameter of AAA together with its growth rate is the only measure available today to 
evaluate the risk of rupture (Vardulaki, Prevost et al. 1998). To date there is no plasma 
tests that can predict the risk of rupture.  Most AAAs produce ILT, which predominantly 
is made of fibrin that is a result of coagulation activity. The fibrin produced is degraded 
later during a process called fibrinolysis that degrades fibrin in healthy situations. Plasmin 
is the predominant protease in this process. However in AAA patients this process is 
halted to certain degree due to unknown reason and ILT grows in volume continually but 
also degrades to certain extent. Degraded ILT predisposes the AAA to rupture. This has 
been shown in plasma by measuring the elevated level of D-dimer of AAA patients and 
its significant  correlation to growth rate of AAA. 
Neutrophil Elastase causes Fibrinolysis of the Intraluminal Thrombus 
of Abdominal Aortic Aneurysm
Jesper SwedenborgI, Angela SilveiraII , Maggie FolkessonI, Jan EngströmIII,  Per 
ErikssonII 
IDepartment of Molecular Medicine and Surgery,  IIDepartment of Medicine, Center for Molecular Medicine,  IIIDepartment of  
Radiology Karolinska University Hospital, Stockholm, Sweden. Karolinska Institutet, Stockholm, Sweden. 
Introduction  
AAA patients experience few or no symptoms during disease progression. Aneurysm 
diameter can be measured by ultrasonography (US), which is a non-invasive procedure. 
US can provide information about risk of rupture by determining if the aneurysm diameter 
is equal to or exceeds 5.5 cm (2002). AAAs often have an intraluminal thrombus (ILT) 
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Hans, 2005 #188}, the growth of which is associated with AAA diameter (Parr, McCann 
et al. 2011), implying that most AAAs with a diameter indicating risk of rupture contain 
an ILT. The ILT has been reported to be of importance for the pathogenesis of AAA (Roy, 
Labruto et al. 2006). 
Neutrophil leucocytes and platelets are found in the luminal layer of the ILT (Houard, 
Touat et al. 2009). Neutrophils contain elastase (NE), a serine protease released from the 
azurophilic granules that is capable of degrading elastin. In addition, NE has fibrinolytic 
activity resulting in fibrin degradation products (FDPs) with a specific epitope (Kohno, 
Inuzuka et al. 2000). Cathepsin G also released from neutrophil leucocytes has fibrinolytic 
activity, but with much lower potency compared to NE (Kolev, Komorowicz et al. 1996). 
NE also promotes fibrinolysis indirectly by cleaving plasminogen resulting in mini-
plasminogen (Wohner 2008). 
AAA rupture occurs most often in the aneurysm wall covered by a mural thrombus (Simao 
da Silva, Rodrigues et al. 2000). In support of this, bleeding into the ILT identified as a 
crescent sign visible on axial images with contrast enhanced CT indicates risk of rupture 
(Arita, Matsunaga et al. 1997). Bleeding into the ILT is significantly more common in 
patients with ruptured compared to intact AAAs (Roy, Labruto et al. 2008). The entrance 
of blood into the ILT is most likely facilitated by fibrinolysis, which permits bleeding to 
reach the underlying aneurysm wall. 
The present study evaluates NE and plasminogen derived FDPs in aneurysm patients 
scheduled for elective open or endovascular repair surgery. The purpose of this study is to 
evaluate the risk of rupture by measuring levels of NE derived FDPs in plasma of patients 
with AAA. 
Patients and Methods  
Seventy patients, 59 men and 11 women, undergoing elective surgery for AAA were 
included in the study, the mean age was 70.4 years, 70 years for men and 71 for women. 
Blood samples anti-coagulated with citrate obtained prior to surgery were centrifuged 20 
min. at 2500×g followed by 30 min. at 20,000×g to obtain platelet free plasma.
ILT volume was measured on CT images in 59 cases using the volume program of 
Siemens Leonardo Workstation. The selected Hounsfield unit settings were dynamic in 
order to exclude the contrast filled lumen, but still include the complete ILT. Missing 
measurements were due to unavailable CT images performed at other hospitals, no 
contrast, or too thick CT-slices.  
The study was approved by the regional ethics committee and participants gave their 
informed consent. 
Plasma levels of elastase-digests of cross-linked fibrin (elastase XDP) were determined 
with a sandwich ELISA, essentially as described by Kohno et al (Kohno, Inuzuka et 
al. 2000). As in the original publication we used the monoclonal antibody anti-elastase 
XDP clone IF-123 from Cosmo Bio Co. Ltd (Tokyo, Japan) as capture antibody, and 
horseradish peroxidase-labeled anti-human fibrinogen rabbit antibody from DAKO 
(Glostrup, Denmark) as probing antibody. The inter-assay coefficient of variation of 7% 
(n=10) was calculated using samples of coagulation reference plasma from Technoclone 
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GmbH (Vienna, Austria). 
The capture antibody IF-123 has been shown to specifically bind granulocyte elastase 
digest products of fibrinogen/cross-linked fibrin, and not to bind plasmin digests of either 
substrate. For further characterization of the antibody IF-123, we incubated fibrinogen 
(3µmol/L) with elastase (Product E-8140, Sigma), plasmin or reaction buffer alone (0.05M 
Tris, 0.15M NaCl, pH 8.0), proteases at 88nmol/L. Samples were taken with minutes 
intervals for 1 hour, and treated with excess of protease inhibitor cocktail (complete, mini, 
EDTA-free, from Roche). Samples were thereafter analyzed for reactivity in the ELISA 
described above. Incubation of fibrinogen with elastase generated product(s) that reacted 
in the ELISA with IF-123 (seen as increase in OD in the samples taken after 40 minutes 
incubation), which did not occur with incubation with plasmin or buffer alone, (Figure 8). 
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                                      	 Figure 8: Evaluation	of	XDP	recognizing	antibody.
Results
A positive correlation between ILT volume and elastase XDP r = 0.58, p<0.05and 
D-dimer r = 0.53, p<0.05 was found. No similar significant correlations were seen for 
AAA diameter. There was a strong positive correlation between plasma D-dimer and 
elastase XDP r= 0.85 p<0.05. After surgery there was a significant decrease of plasma 
elastase XDP compared to plasma levels of XDP before surgical AAA repair  (Figure 
9). Volume of the ILT is associated with aneurysm diameter, but there were significant 
correlations although weak, for elastase XDP and D-dimer with aneurysm diameter in the 
present study r=0.18 and 0.16 respectively.  
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P<0.01	
Figure 9:	Pre	and	postoperative	levels	of	XDP:	Box-and-whisker	plot	showing	plasma	levels	of	
elastase	derived	fibrinolysis	products	(XDP)	before	and	after	elective	open	repair	surgery	for	
AAA.	P-values	were	computed	using	the	Mann-Whitney	rank-sum	test,	(n=11)
Discussion
The present study shows increased elastase XDP levels in plasma, reflecting neutrophil 
elastase (NE) activity in the ILT. Neutrophils are readily found in the canaliculi of the ILT 
(Figure 10), and are a source of proteases to further degrade the ILT and the aneurysm 
wall.
Figure 10: Luminal	 layer	 of	 the	 ILT	 stained	 with	 neutrophil	 marker	 CD66acd	 (red)	 and	
haematoxylin	 counterstain	 (blue).	 A)	 Image	 shows	 10	 x	 magnification	 with	 negative-control	
image	 in	 the	corner	(no	primary	antibody).	B)	Image	shows	20	x	magnification	where	arrows	
show	canaliculated	tissue	that	allows	entrance	of	the	cells	into	the	ILT.	
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NE also promotes plasmin activity by converting plasminogen into mini- plasminogen, 
which is more readily activated by plasminogen activators. Furthermore NE inhibits 
α2-antiplasmin and PAI-1 (Lerant, Kovacs et al. 1990).  Consequently the correlation 
between elastase XDP and D-dimer can be increased by plasmin fibrinolysis induced 
by NE. Accordingly it could be suspected that NE contributes to an increased level of 
D-dimer, which has been reported to be a marker for presence and growth rate of AAA 
(Golledge, Muller et al. 2011). 
The ILT is not strong enough to withstand pulsatile stress (Gasser, Gorgulu et al. 2008). 
Bleeding into the ILT allowing blood flow to reach the underlying aneurysm wall is likely 
based on weakness of the ILT caused by fibrinolysis. In addition to NE, degradation 
of fibrin is caused by other neutrophil derived enzymes namely cathepsin G (Kolev, 
Komorowicz et al. 1996) and membrane type 1-MMP (Kluft 2003), the latter originates 
from neutrophil microvesicles, which have been found in the ILT (Own unpublished 
observations). 
The AAA wall covered by a thick ILT is thinner and less resistant to wall stress compared 
to wall segments with only a thin or not macroscopically detectable ILT (Vorp, Lee et al. 
2001). Identification of bleeding in the ILT by localized areas with higher attenuation in 
coronal, axial and sagittal projections have been shown in significantly more cases with 
ruptured compared to intact AAAs (Roy, Labruto et al. 2008). Accordingly fibrinolysis in 
the ILT amplified by NE could increase the risk of AAA rupture.
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concLusion 
In this thesis, we concentrated on the ILT of AAA. Previous studies have suggested that 
the ILT could play an active role in AAA development.  Because the ILT is present in 
most large AAAs, its effect on the underlying vessel wall should be considered. The 
biomechanical effects of the ILT have been shown to be important in calculating the 
risk of AAA rupture. The presence of proteases in the ILT and the aortic wall was the 
main concern of this thesis. We started with MMP9 and its binding partner, N-GAL that 
protects it from degradation. In paper I, we could show that they form a complex in AAA 
tissue, which could lead to preserved activity of MMP9. 
In paper II, we investigated the presence of soluble proteases and their inhibitors in the 
ILT, to try to explain the reason for the aortic wall under the ILT (TVW) being thinner 
and more degraded than the wall that is not under the ILT (NTVW). Proteases, such as 
neutrophil elastase and MMP9, have been shown to play active roles in the pathogenesis 
of AAA. Nevertheless, we found that the activity of these proteases in the abluminal layer 
of the ILT was very low or close to zero. This could be the result of inhibitors such as a-1 
anti-trypsin and TIMP1. These inhibitors are present in the ILT with higher concentrations 
in the abluminal layer of the ILT compared to the other layers. This was the layer where 
the activities of soluble proteases were shown to be the lowest.
In this process we have learnt that there might not be such thing as ILT free wall in our 
samples but aortic wall exposed to ILT in different length of time. The noteworthy point 
that should be kept in mind here is the fact that the sample collection was only available 
at the later stage of the disease. 
Observing these aorta segments in a microscope, (Figure 1), we noticed that there always 
exist some ILT covering the aortic wall, even the one considered free from the ILT 
deduced by CT-images. This wall is the wall shown to have a higher mRNA expression of 
MMPs than the wall covered with the ILT in previous study by our group. The proteases 
in the luminal layer of the ILT are the most active. This layer resembles the thin thrombus 
that covers the so called “thrombus free wall”. Investigating this wall may be important 
for the understanding of what happens during the early stages of AAA development. 
In paper III, we examined a physically distinct class of proteases, the transmembrane 
ADAM proteases.  We found that ADAM10 and ADAM17 (also known as TACE) are 
abundant and enzymatically active in the ILT and AAA aortic wall. Importantly, ADAMs 
are present in the abluminal layer of the ILT, immediately adjacent to the aortic wall. 
We found that these molecules are embedded in the membrane of MVs that had bud 
off from cells in AAA tissue. Neutrophils and platelets are among the cells that produce 
proteolyltically active MVs in AAA tissue. Interestingly, exposure of neutrophils in vitro 
to tobacco smoke extract induced the production of MVs that carry active ADAMs on 
their membrane.
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In an ongoing project investigating the effect of NE on fibrin mesh of ILT, we found a 
significant correlation between elastase-digests of cross-linked fibrin (elastase XDP) in 
plasma of AAA patient  and volume of the ILT. Further investigations are required to 
determine levels of XDP in plasma of AAA patients compared to the control plasma. 
Overall, we have shown in this thesis that the ILT may have a role in the pathogenesis 
of AAA. The ILT stores cells and proteases in its mesh and could thereby damage the 
underlying aortic wall. 
Figure 1:	Aneurysmal	 aorta	 free	 from	 the	 ILT	 stained	with	Masson’s	Trichrome	
where	muscles	 that	stains	red	are	not	present	but	over	production	of	collagen	 in	
light	blue	is	seen.	The	top	layer	that	is	red	and	is	indicated	by	the	arrow	shows	a	
thin	layer	of	ILT	covering	what	is	left	of	the	endothelial	layer,	10x	magnification.	
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